Processing 00000000.tx.1: Recognition of Misfolding Proteins by PA700, the Regulatory Subcomplex of the 26S Proteasome* Elizabeth Strickland, Kevin Hakala, Philip J. 

Phrase: "Recognition of Misfolding Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0524637:Recognition [Mental Process]

Phrase: "by PA700,"

Phrase: "the Regulatory Subcomplex of the 26S Proteasome"

Phrase: "* Elizabeth Strickland,"

Phrase: "Kevin Hakala,"

Phrase: "Philip J."
Processing 00000000.tx.2: Thomas, and George N. 

Phrase: "Thomas,"

Phrase: "and"

Phrase: "George N."
Processing 00000000.tx.3: DeMartino From the Program in Molecular Biophysics and the Department of Physiology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75235  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The 26S proteasome is a large protease complex that catalyzes the degradation of both native and misfolded proteins. 

Phrase: "DeMartino From the Program"

Phrase: "in Molecular Biophysics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005553:Biophysics [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "the Department of Physiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "University of Texas Southwestern Medical Center at Dallas,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   793   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   770   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   770   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   744   C0039711:Texas [Geographic Area]
   744   C0041740:University [Manufactured Object,Organization]
   744   C0205099:Center [Spatial Concept]
   744   C0205476:Medical [Functional Concept]
   744   C1710136:Southwestern [Spatial Concept]

Phrase: "Dallas,"

Phrase: "Texas 75235  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0557061:Discussion [Therapeutic or Preventive Procedure]
   790   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The 26S proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "is"

Phrase: "a large protease complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "catalyzes"

Phrase: "the degradation of both native"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "misfolded proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.4: These proteins are known to interact with PA700, the regulatory subcomplex of the 26S proteasome, via a covalently attached polyubiquitin chain. 

Phrase: "These proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with PA700,"

Phrase: "the regulatory subcomplex of the 26S proteasome,"

Phrase: "via a covalently attached polyubiquitin chain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0337112:Chain [Manufactured Object]
   812   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.5: Here we provide evidence for an additional ubiquitin-independent mode of substrate recognition by PA700. 

Phrase: "Here"

Phrase: "we"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence for an additional ubiquitin-independent mode of substrate recognition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "by PA700."
Processing 00000000.tx.6: PA700 prevents the aggregation of three incompletely folded, nonubiquitinated substrates: the F-508 mutant form of cystic fibrosis transmembrane regulator, nucleotide binding domain 1,insulin B chain, and citrate synthase. 

Phrase: "PA700"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the aggregation of three incompletely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "folded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Folded [Spatial Concept]
  1000   C1880834:FOLDED [Phenomenon or Process]

Phrase: ","

Phrase: "nonubiquitinated substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: ":"

Phrase: "the F-508 mutant form of cystic fibrosis transmembrane regulator,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   758   C0449597:Form of cyst [Spatial Concept]
   739   C0348078:Form [Qualitative Concept]
   739   C0376315:Form [Manufactured Object]
   739   C1522492:Form [Functional Concept]

Phrase: "nucleotide binding domain 1,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C1148916:nucleotide binding [Molecular Function]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "insulin B chain,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "citrate synthase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413745:citrate synthase [Gene or Genome]
   861   C0008857:Citrate [Organic Chemical]
   861   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.7: This function does not require ATP hydrolysis. 

Phrase: "This function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "ATP hydrolysis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510699:ATP Hydrolysis [Molecular Function]
   861   C0020291:Hydrolysis [Natural Phenomenon or Process]
Processing 00000000.tx.8: The stoichiometry required for this function, the effect of PA700 on the lag phase of aggregation, and the temporal specificity of PA700 in this process all indicate that PA700 interacts with a subpopulation of non-native conformations that is either particularly aggregation-prone or nucleates misassociation reactions. 

Phrase: "The stoichiometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597526:Stoichiometry [Quantitative Concept]

Phrase: "required for this function,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1514873:Required [Functional Concept]
   770   C1705273:Function [Intellectual Product]

Phrase: "the effect of PA700"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the lag phase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205390:Phase [Temporal Concept]
   861   C1416797:Lag [Gene or Genome]

Phrase: "of aggregation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "the temporal specificity of PA700"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "in this process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "all"

Phrase: "indicate"

Phrase: "that PA700"

Phrase: "interacts with a subpopulation of non-native conformations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0302891:Native [Functional Concept]
   744   C1257890:Subpopulation [Population Group]
   744   C1518422:Non [Functional Concept]
   711   C0026377:Conformation [Spatial Concept]

Phrase: "that"

Phrase: "is"

Phrase: "either particularly aggregation-prone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033422:Prone [Spatial Concept]

Phrase: "or"

Phrase: "nucleates"

Phrase: "misassociation reactions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.9: The inhibition of off-pathway self-association reactions is also reflected in the ability of PA700 to promote refolding of citrate synthase. 

Phrase: "The inhibition of"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "off-pathway self-association reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0443286:Reaction [Functional Concept]
   779   C1114821:Reaction [Clinical Attribute]

Phrase: "is"

Phrase: "also"

Phrase: "reflected in the ability of PA700 to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0085732:Ability [Organism Attribute]
   748   C0558058:reflected [Mental Process]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "refolding of citrate synthase."
Processing 00000000.tx.10: These results provide evidence that, in addition to binding polyubiquitin chains, PA700 contains a site(s) that recognizes and interacts with misfolded or partially denatured polypeptides. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that,"

Phrase: "in addition to binding polyubiquitin chains,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0337112:chains [Manufactured Object]
   827   C1524075:Chains [Idea or Concept]

Phrase: "PA700"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "("

Phrase: "s)"

Phrase: "that"

Phrase: "recognizes"

Phrase: "and"

Phrase: "interacts with misfolded"

Phrase: "or"

Phrase: "partially denatured polypeptides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.11: This feature supplies an additional level of substrate specificity to the 26S proteasome and a means by which substrates are maintained in a soluble state until refolding or degradation is complete.  

Phrase: "This feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521970:Feature [Qualitative Concept]
  1000   C1706388:Feature [Conceptual Entity]
  1000   C2346469:Feature [Qualitative Concept]
  1000   C2348519:Feature [Qualitative Concept]

Phrase: "supplies"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0038848:Supplies [Manufactured Object]
  1000   C0243163:supply [Idea or Concept]
  1000   C0699914:supply [Quantitative Concept]
  1000   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
  1000   C1561604:supply [Functional Concept]
  1000   C1875802:SUPPLY [Medical Device]
  1000   C1999230:Supply [Activity]

Phrase: "an additional level of substrate specificity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "to the 26S proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "a means by which substrates"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1704970:Means [Conceptual Entity]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]

Phrase: "are"

Phrase: "maintained in a soluble state"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C1301808:State [Geographic Area]
   760   C1314677:Maintained [Functional Concept]
   760   C1442792:State [Functional Concept]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]
   760   C3148680:State [Geographic Area]
   726 E C0024501:Maintain [Activity]

Phrase: "until refolding"

Phrase: "or"

Phrase: "degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "complete."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205197:Complete [Qualitative Concept]
  1000   C0725685:COMPLEAT [Food]
   928 E C0439812:Completeness [Qualitative Concept]
Processing 00000000.tx.12: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The 26S proteasome is a large proteolytic machine that participates in nearly all of the multiple roles played by intracellular protein degradation in cellular function (reviewed in Refs. 1-3). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The 26S proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "is"

Phrase: "a large proteolytic machine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0336779:Machine [Manufactured Object]

Phrase: "that"

Phrase: "participates in nearly"

Phrase: "all of the multiple roles"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0035820:Roles [Social Behavior]
   760   C0439064:Multiple [Quantitative Concept]
   760   C0444868:All [Quantitative Concept]
   760   C3539085:All [Idea or Concept]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "played by intracellular protein degradation"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0597297:Protein Degradation [Molecular Function]
   806   C0597304:Protein Degradation [Molecular Function]
   806   C1623036:Protein Degradation [Molecular Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0243125:degradation [Functional Concept]
   760   C0600138:played [Finding]
   760   C0699900:Degradation [Organism Function]
   726 E C0032214:Play [Daily or Recreational Activity]

Phrase: "in cellular function"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0007613:Cellular Function [Cell Function]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "("

Phrase: "reviewed in Refs. 1-3"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0140145:REF-1 [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1332102:REF-1 [Gene or Genome]
   760   C0282443:reviewed [Intellectual Product]
   760   C1425988:REF [Gene or Genome]
   760   C1709940:Reviewed [Qualitative Concept]
   726 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.13: For example, the proteasome catalyzes both the constitutive turnover of the bulk of intracellular proteins and the conditional degradation of specific proteins that regulate various cellular processes. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "catalyzes"

Phrase: "both the constitutive turnover of the bulk of intracellular proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   741   C0597297:Protein Turnover [Molecular Function]
   739   C0031227:turnover [Quantitative Concept]
   739   C0243127:turnover [Functional Concept]
   739   C0443331:Turnover [Health Care Activity]

Phrase: "and"

Phrase: "the conditional degradation of specific proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0597297:Protein Degradation [Molecular Function]
   767   C0597304:Protein Degradation [Molecular Function]
   767   C1623036:Protein Degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "that"

Phrase: "regulate"

Phrase: "various cellular processes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0007613:Cellular Process [Cell Function]
   884   C1325880:cellular process [Cell Function]
   793   C1184743:Process [Body Part, Organ, or Organ Component]
   793   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.14: The 26S proteasome is also a component of the quality control machinery that selectively degrades proteins with abnormal structures. 

Phrase: "The 26S proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "is"

Phrase: "also"

Phrase: "a component of the quality control machinery"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "that selectively"

Phrase: "degrades"

Phrase: "proteins with abnormal structures."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   819   C0311448:abnormal proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   786   C0175168:protein structure [Amino Acid, Peptide, or Protein]
   786   C1510464:Protein Structure [Amino Acid, Peptide, or Protein]
   777 E C0582263:structural proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.15: Most known protein substrates of the 26S proteasome are covalently modified with a polyubiquitin chain as a prerequisite for their proteolysis (1, 2). 

Phrase: "Most known protein substrates of the 26S proteasome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1710236:Substrate [Manufactured Object]

Phrase: "are"

Phrase: "covalently"

Phrase: "modified with a polyubiquitin chain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0084133:Polyubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0337112:Chain [Manufactured Object]
   760   C0392747:Modified [Functional Concept]
   760   C1421267:POLYUBIQUITIN [Gene or Genome]
   760   C1524075:Chain [Idea or Concept]

Phrase: "as a prerequisite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679209:prerequisite [Idea or Concept]

Phrase: "for their proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: This requirement seems to have evolved, at least in part, because of the unique structure of the 26S proteasome. 

Phrase: "This requirement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Requirement [Functional Concept]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "evolved,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332253:evolved [Functional Concept]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "because of the unique structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "of the 26S proteasome."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.17: The 26S proteasome is composed of two 700,000-dalton subcomplexes, the 20S proteasome and PA7001 (1, 2, 4). 

Phrase: "The 26S proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "is"

Phrase: "composed of two 700,000-dalton subcomplexes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205448:Two [Quantitative Concept]
   748   C0678223:dalton [Quantitative Concept]

Phrase: "the 20S proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
  1000   C1166808:20S proteasome [Cell Component]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "PA7001"

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.18: The 20S proteasome, the catalytic core of the complex, is a cylindrical particle consisting of four stacked heptameric rings that contain a hollow center in which all six of the catalytic sites are located (5, 6). 

Phrase: "The 20S proteasome,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
  1000   C1166808:20S proteasome [Cell Component]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "the catalytic core of the complex,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0600499:Catalytic Core [Amino Acid Sequence]
   753   C0444669:Core [Spatial Concept]
   753   C1167518:core [Cell Component]
   753   C1706352:Core [Medical Device]
   753   C1882467:Core [Manufactured Object]
   753   C3274653:Core [Body Substance]

Phrase: "is"

Phrase: "a cylindrical particle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597177:Particle [Chemical Viewed Structurally]

Phrase: "consisting of four"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205450:Four [Quantitative Concept]
   756   C0332529:CONSIST [Qualitative Concept]

Phrase: "stacked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3272897:Stack [Spatial Concept]

Phrase: "heptameric rings"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1260969:Rings [Medical Device]
   827 E C0521164:Ring [Spatial Concept]
   827 E C1705184:Ring [Medical Device]

Phrase: "that"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a hollow center in which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205099:Center [Spatial Concept]

Phrase: "all six of the catalytic sites"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0205681:Sites, Catalytic [Functional Concept]
   783   C1510853:All Sites [Spatial Concept]
   767   C2945843:Site of [Qualitative Concept]
   756 E C0600499:catalytic site [Amino Acid Sequence]
   753   C0007382:Catalytic [Natural Phenomenon or Process]
   753   C0205145:Sites [Spatial Concept]
   753   C0205452:Six [Quantitative Concept]
   753   C0444868:All [Quantitative Concept]
   753   C3539085:All [Idea or Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "located"

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.19: This topology excludes both folded and aggregated substrates from contact with, and hydrolysis by, the active sites. 

Phrase: "This topology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002812:Topology [Biomedical Occupation or Discipline]

Phrase: "excludes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "both folded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Folded [Spatial Concept]
  1000   C1880834:FOLDED [Phenomenon or Process]

Phrase: "and"

Phrase: "aggregated substrates from contact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710236:Substrate [Manufactured Object]

Phrase: "with,"

Phrase: "and"

Phrase: "hydrolysis by,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "the active sites."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0205681:Sites, Active [Functional Concept]
   861   C0205145:Sites [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.20: The role of initial substrate recognition and binding by the complex is relegated to PA700, a 20-subunit regulatory complex (7-9). 

Phrase: "The role of initial substrate recognition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "binding by the complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "relegated to PA700,"

Phrase: "a 20-subunit regulatory complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(7-9"

Phrase: ")."
Processing 00000000.tx.21: Because the 26S proteasome typically requires polyubiquitinated protein substrates for degradation, the polyubiquitin chain binding site on PA700 (10-12) is an important determinant of substrate specificity. 

Phrase: "Because"

Phrase: "the 26S proteasome typically"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1166804:26S proteasome [Cell Component]
   827   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325620:proteasome [Cell Component]
   827   C1552140:26s [Body Part, Organ, or Organ Component]
   827   C1752727:Proteasome [Molecular Function]

Phrase: "requires"

Phrase: "polyubiquitinated protein substrates for degradation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1710236:Substrate [Manufactured Object]

Phrase: "the polyubiquitin chain binding site on PA700"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0005456:Binding Site [Receptor]
   778   C0682969:Binding Site [Amino Acid Sequence]
   774   C1621498:polyubiquitin binding [Molecular Function]
   748   C0205145:Site [Spatial Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "(10-12"

Phrase: ")"

Phrase: "is"

Phrase: "an important determinant of substrate specificity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521761:Determinant [Functional Concept]
Processing 00000000.tx.22: In addition to binding protein substrates, PA700 also regulates the access of substrates to the active sites of the proteasome. 

Phrase: "In addition to binding protein substrates,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1710236:Substrate [Manufactured Object]
   734   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "PA700 also"

Phrase: "regulates"

Phrase: "the access of substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0444454:Access [Spatial Concept]
   770   C1554204:access [Idea or Concept]

Phrase: "to the active sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0205681:Sites, Active [Functional Concept]
   861   C0205145:Sites [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "of the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.23: ATP-dependent binding of PA700 to the outer rings of the proteasome probably induces a conformational change in the proteasome that creates narrow pores in the center of the outer rings, thereby exposing the interior catalytic sites to the exterior (2, 3, 13, 14). 

Phrase: "ATP-dependent binding of PA700"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1148923:ATP binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to the outer rings"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1260969:Rings [Medical Device]
   827 E C0521164:Ring [Spatial Concept]
   827 E C1705184:Ring [Medical Device]

Phrase: "of the proteasome probably"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a conformational change in the proteasome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0301641:Conformational change [Molecular Function]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "creates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "narrow pores in the center of the outer rings,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1325742:Pore [Cell Component]

Phrase: "thereby"

Phrase: "exposing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:exposing [Clinical Attribute]

Phrase: "the interior catalytic sites to the exterior"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   778   C0205681:Sites, Catalytic [Functional Concept]
   748   C0007382:Catalytic [Natural Phenomenon or Process]
   748   C0205145:Sites [Spatial Concept]
   745 E C0600499:catalytic site [Amino Acid Sequence]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.24: This effect explains, in part, the PA700-dependent activation of the proteasome's hydrolysis of short nonubiquitinated peptides, which can freely cross the pores without need for interaction with or structural modification by PA700 (8). 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "explains"

Phrase: ","

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "the PA700-dependent activation of the proteasome's hydrolysis of short nonubiquitinated peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1879547:Activation [Activity]

Phrase: "which"

Phrase: "can"

Phrase: "freely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879743:Freely [Qualitative Concept]

Phrase: "cross"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828360:Cross [Conceptual Entity]

Phrase: "the pores without need"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1325742:Pore [Cell Component]

Phrase: "for interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "with"

Phrase: "or"

Phrase: "structural modification by PA700"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0581602:Structural modification [Therapeutic or Preventive Procedure]
   770   C0392747:Modification [Functional Concept]
   770   C1554963:modification [Qualitative Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.25: In contrast, the PA700-dependent opening of pores in the proteasome does not explain fully how PA700 promotes the degradation of ubiquitinated proteins with native or partially folded structures because such proteins are too large to traverse the pores (15). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the PA700-dependent opening of pores"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0175566:Opening [Spatial Concept]
   753   C1882151:Opening [Spatial Concept]

Phrase: "in the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "explain"

Phrase: "fully how PA700"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the degradation of ubiquitinated proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1519750:Ubiquitinated Protein Degradation [Molecular Function]
   781   C0597297:Protein Degradation [Molecular Function]
   781   C0597304:Protein Degradation [Molecular Function]
   781   C1623036:Protein Degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "with native"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0302891:Native [Functional Concept]

Phrase: "or"

Phrase: "partially folded structures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0332462:Folded structure [Spatial Concept]
   827   C0678594:structures [Spatial Concept]

Phrase: "because"

Phrase: "such proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "too large to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0549177:Large [Quantitative Concept]

Phrase: "traverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828360:Traverse [Conceptual Entity]

Phrase: "the pores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1325742:Pore [Cell Component]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.26: Therefore, it is commonly assumed that as an essential feature of 26S proteasome-catalyzed proteolysis, PA700 must unfold the bound, ubiquitinated proteins and processively translocate them through the pores to the catalytic sites of the proteasome. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "is"

Phrase: "commonly"

Phrase: "assumed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242379:Assumed [Intellectual Product]

Phrase: "that"

Phrase: "as"

Phrase: "an essential feature of 26S proteasome-catalyzed proteolysis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1521970:Feature [Qualitative Concept]
   744   C1706388:Feature [Conceptual Entity]
   744   C2346469:Feature [Qualitative Concept]
   744   C2348519:Feature [Qualitative Concept]

Phrase: "PA700"

Phrase: "must"

Phrase: "unfold"

Phrase: "the bound, ubiquitinated proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1956096:Ubiquitinated Proteins [Amino Acid, Peptide, or Protein]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "processively"

Phrase: "translocate"

Phrase: "them through the pores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1325742:Pore [Cell Component]

Phrase: "to the catalytic sites"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0205681:Sites, Catalytic [Functional Concept]
   966 E C0600499:catalytic site [Amino Acid Sequence]
   861   C0007382:Catalytic [Natural Phenomenon or Process]
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "of the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.27: This model would explain the known ATP requirement for degradation of ubiquitinated proteins by the assembled 26S proteasome, because it predicts that substrate unfolding and/or translocation are coupled to ATP hydrolysis by one or more of the six AAA protein subunits of PA700 (7, 13, 14, 16). 

Phrase: "This model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "would"

Phrase: "explain"

Phrase: "the known ATP requirement for degradation of ubiquitinated proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C0556043:Protein requirement [Finding]
   742   C1514873:Requirement [Functional Concept]

Phrase: "by the assembled 26S proteasome,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1166804:26S proteasome [Cell Component]
   827   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325620:proteasome [Cell Component]
   827   C1552140:26s [Body Part, Organ, or Organ Component]
   827   C1752727:Proteasome [Molecular Function]

Phrase: "because"

Phrase: "it"

Phrase: "predicts"

Phrase: "that substrate unfolding"

Phrase: "and/or"

Phrase: "translocation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040715:Translocation [Cell or Molecular Dysfunction]
  1000   C2987521:Translocation [Activity]

Phrase: "are"

Phrase: "coupled to ATP hydrolysis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1510699:ATP Hydrolysis [Molecular Function]
   770   C0020291:Hydrolysis [Natural Phenomenon or Process]
   770   C1948027:Coupled [Functional Concept]
   737 E C0010222:couple [Family Group]

Phrase: "by one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "more of the six AAA protein subunits of PA700"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0599220:Protein Subunits [Amino Acid, Peptide, or Protein]
   762   C1518774:PA700 Protein [Cell Component]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205172:More [Functional Concept]
   742   C0205452:Six [Quantitative Concept]
   708   C1711351:Subunit [Quantitative Concept]

Phrase: "(7,"

Phrase: "13,"

Phrase: "14,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.28: This attractive model, however, has little direct experimental support and, with the exception of ATPase activity, the properties of PA700 required for such activities are poorly defined. 

Phrase: "This attractive model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "however,"

Phrase: "has"

Phrase: "little direct experimental support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0183683:Support [Medical Device]
   812   C1521721:Support [Conceptual Entity]

Phrase: "and"

Phrase: ","

Phrase: "with the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of ATPase activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1148926:ATPase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "the properties of PA700"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0871161:properties [Qualitative Concept]
   770   C1292721:properties [Functional Concept]
   737 E C1882134:Property [Conceptual Entity]
   737 E C2347695:Property [Entity]

Phrase: "required for such activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0441655:Activities [Activity]
   770   C1514873:Required [Functional Concept]
   737 E C0205177:Activity [Functional Concept]
   737 E C0439167:% activity [Quantitative Concept]
   737 E C1561536:*Activity [Idea or Concept]

Phrase: "are"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "defined."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.29: To mediate unfolding and/or translocation, PA700 must contain a binding site for the non-native structures characteristic of both the products of the unfolding reaction and the substrates for the translocation reaction. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "unfolding"

Phrase: "and/or"

Phrase: "translocation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040715:Translocation [Cell or Molecular Dysfunction]
  1000   C2987521:Translocation [Activity]

Phrase: "PA700"

Phrase: "must"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a binding site for the non-native structures"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0005456:Binding Site [Receptor]
   770   C0682969:Binding Site [Amino Acid Sequence]
   744   C0205145:Site [Spatial Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1515974:Site [Body Location or Region]
   744   C2825164:Site [Spatial Concept]

Phrase: "characteristic of both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1521970:Characteristic [Qualitative Concept]

Phrase: "the products of the unfolding reaction"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1514468:Products [Entity]
   719 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "the substrates for the translocation reaction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.30: Precendent exists for this from studies of the bacterial Clp protease system, which, like the proteasome, has occluded active sites and capping ATPases ClpA and ClpX. 

Phrase: "Precendent"

Phrase: "exists for this from studies of the bacterial Clp protease system,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   756   C0052605:Clp Protease [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   738   C0449913:System [Functional Concept]
   738   C0521009:Bacterial [Qualitative Concept]
   738   C0947630:studies [Laboratory Procedure]
   738   C1553451:System [Manufactured Object]
   738   C1704459:System [Medical Device]
   738   C1947941:Protease [Enzyme]
   738   C2987476:Exist [Conceptual Entity]
   704 E C0557651:Study [Manufactured Object]
   704 E C2603343:Study [Research Activity]

Phrase: "which,"

Phrase: "like the proteasome,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "has"

Phrase: "occluded active sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0205681:Sites, Active [Functional Concept]
   827   C0205145:Sites [Spatial Concept]
   827   C0205177:Active [Functional Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "capping ATPases ClpA"

Phrase: "and"

Phrase: "ClpX."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413508:CLPX [Gene or Genome]
Processing 00000000.tx.31: These AAA ATPases are known to mediate molecular chaperone and unfoldase activities (17-20). 

Phrase: "These AAA ATPases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001473:ATPases [Amino Acid, Peptide, or Protein,Enzyme]
   827 E C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "molecular chaperone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243041:Molecular Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Chaperone

Phrase: "and"

Phrase: "unfoldase activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "(17-20"

Phrase: ")."
Processing 00000000.tx.32: To gain insight into the recognition of protein substrates by PA700 we have analyzed interactions of PA700 with several model proteins in native and non-native conformations. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "insight into the recognition of protein substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0233820:Insight [Mental Process]

Phrase: "by PA700"

Phrase: "we"

Phrase: "have"

Phrase: "analyzed interactions of PA700"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704675:Interaction [Functional Concept]

Phrase: "with several model proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in native"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0302891:Native [Functional Concept]

Phrase: "and"

Phrase: "non-native conformations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.33: Our data demonstrate that PA700 can directly interact with non-native structures of nonubiquitinated proteins and suggest models for how such interactions can participate in the degradation or refolding of protein substrates.  

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that PA700"

Phrase: "can"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "interact with non-native structures of nonubiquitinated proteins"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0302891:Native [Functional Concept]
   744   C0678594:structures [Spatial Concept]
   744   C1518422:Non [Functional Concept]
   734   C0175168:protein structure [Amino Acid, Peptide, or Protein]
   734   C1510464:Protein Structure [Amino Acid, Peptide, or Protein]
   725 E C0582263:structural proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "models for how"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3161035:Models [Intellectual Product]

Phrase: "such interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "can"

Phrase: "participate in the degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "or"

Phrase: "refolding of protein substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   819   C1158944:Protein Refolding [Molecular Function]
Processing 00000000.tx.34: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Materials-- PA700 (21), latent 20S proteasome, PA28, and modulator were purified from bovine red blood cells as described previously (8, 22, 23). 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "--"

Phrase: "PA700"

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "latent 20S proteasome,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
   901   C1166808:20S proteasome [Cell Component]
   827   C1325620:proteasome [Cell Component]
   827   C1752727:Proteasome [Molecular Function]

Phrase: "PA28,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1166811:PA28 [Cell Component]

Phrase: "and"

Phrase: "modulator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709060:Modulator [Manufactured Object]

Phrase: "were"

Phrase: "purified from bovine red blood cells"
Meta Candidates (Total=20; Excluded=4; Pruned=0; Remaining=16)
   833   C0014772:Red Blood Cells [Laboratory Procedure]
   833   C0014792:Red Blood Cells [Cell]
           Red cells
   833   C0439179:% red blood cells [Quantitative Concept]
   833   C1277078:Red blood cells [Pharmacologic Substance]
   790   C0005773:Blood Cells [Cell]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0007452:Bovine [Mammal]
   753   C0007634:Cells [Cell]
   753   C0229664:Blood [Body Substance]
   753   C0332575:Red [Finding]
   753   C1140701:bovine [Mammal]
   753   C1260956:Red [Qualitative Concept]
   753   C1998793:Purified [Functional Concept]
   753   C3282337:Cells [Cell]
   745 E C2328697:Hemal cell [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(8,"

Phrase: "22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.35: "Lid" and "base" subcomplexes of PA700 were identified during the purification of PA700 from bovine red blood cells and are essentially equivalent to their counterparts in yeast (24). 

Phrase: """Lid"""

Phrase: "and """

Phrase: "base"" subcomplexes of PA700"

Phrase: "were"

Phrase: "identified during the purification of PA700"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205396:Identified [Qualitative Concept]
   753   C0243114:purification [Functional Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1998793:Purification [Functional Concept]

Phrase: "from bovine red blood cells"
Meta Candidates (Total=26; Excluded=11; Pruned=0; Remaining=15)
   923   C0014772:Red Blood Cells [Laboratory Procedure]
   923   C0014792:Red Blood Cells [Cell]
           Red cells
   923   C0439179:% red blood cells [Quantitative Concept]
   923   C1277078:Red blood cells [Pharmacologic Substance]
   861   C0005773:Blood Cells [Cell]
   816 E C2328697:Hemal cell [Cell]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0007452:Bovine [Mammal]
   812   C0007634:Cells [Cell]
   812   C0229664:Blood [Body Substance]
   812   C0332575:Red [Finding]
   812   C1140701:bovine [Mammal]
   812   C1260956:Red [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "essentially equivalent to their counterparts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205163:Equivalent [Qualitative Concept]
   760   C0439185:equivalent [Quantitative Concept]

Phrase: "in yeast"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036025:yeast [Fungus]
  1000   C0043392:Yeast [Food]
  1000   C0043393:Yeast [Fungus]
  1000   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.36: Lid was purified as an isolated complex, whereas, the base was purified bound to 20S proteasome. 

Phrase: "Lid"

Phrase: "was"

Phrase: "purified as an isolated complex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205409:Isolated [Functional Concept]
   760   C0439855:Complex [Qualitative Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]
   760   C1998793:Purified [Functional Concept]

Phrase: "whereas"

Phrase: ","

Phrase: "the base"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002055:base [Inorganic Chemical]
  1000   C0178499:Base [Chemical Viewed Functionally]
  1000   C1880279:Base [Biomedical or Dental Material]
   928 E C0205112:Basal [Spatial Concept]
   916 E C0016617:Foundation [Organization]
   916 E C1626935:Bases [Quantitative Concept]

Phrase: "was"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "bound to 20S proteasome."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
   833   C1166808:20S proteasome [Cell Component]
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1325620:proteasome [Cell Component]
   770   C1552134:20s [Body Part, Organ, or Organ Component]
   770   C1689898:% bound [Quantitative Concept]
   770   C1752727:Proteasome [Molecular Function]
   770   C2349209:Bound [Conceptual Entity]
Processing 00000000.tx.37: Details of the purification and characterization of these complexes will be published elsewhere.2 F508 mutant CFTR-NBD1 from residues 404-589 was expressed with a six-histidine tag and purified as described previously (25). 

Phrase: "Details of the purification"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1522508:Details [Qualitative Concept]
   737 E C1561567:detail [Functional Concept]

Phrase: "and"

Phrase: "characterization of these complexes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "will"

Phrase: "be"

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "elsewhere.2 F508 mutant CFTR-NBD1 from residues 404-589"

Phrase: "was"

Phrase: "expressed with a six-histidine tag"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0037293:Tag [Neoplastic Process]
   753   C0181496:Tag [Manufactured Object]
   753   C0205452:Six [Quantitative Concept]
   753   C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.38: Porcine heart citrate synthase was purchased from Sigma; 

Phrase: "Porcine heart citrate synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1413745:citrate synthase [Gene or Genome]
   812   C0008857:Citrate [Organic Chemical]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "purchased from Sigma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.39: it was dialyzed into TE buffer (50mM Tris-HCl, pH 8.0,2mM EDTA), concentrated to 4.65mg/ml, and stored at 20C in aliquots. 

Phrase: "it"

Phrase: "was"

Phrase: "dialyzed into TE buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0039462:Te [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C1705540:TE [Conceptual Entity]

Phrase: "(50mM Tris-HCl,"

Phrase: "pH 8.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "2mM EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "concentrated to 4.65mg/ml,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0439526:/mL [Quantitative Concept]
   760   C1880165:Concentrated [Biomedical or Dental Material]
   726 E C1880310:Concentrate [Manufactured Object]
   726 E C2003864:Concentrate [Substance]

Phrase: "and"

Phrase: "stored at 20C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]

Phrase: "in aliquots."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510844:Aliquot [Quantitative Concept]
Processing 00000000.tx.40: Porcine insulin was from Calbiochem. 

Phrase: "Porcine insulin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0724601:Porcine Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C0770206:Porcine insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0039005:porcine [Mammal]
   861   C1135183:Porcine, NOS [Mammal]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was from Calbiochem."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.41: Aggregation of F-NBD1-- Aggregation of F-NBD1 was performed as described previously (26) at 2M final protein concentration in Buffer R (100mM Tris-HCl, pH 7.4,0.385M L-arginine hydrochloride, 2mM EDTA, 10mM dithiothreitol, and 25mM guanidine hydrochloride (GdnHCl)). 

Phrase: "Aggregation of F-NBD1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "--"

Phrase: "Aggregation of F-NBD1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(26"

Phrase: ")"

Phrase: "at 2M final protein concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0427716:Protein concentration [Laboratory Procedure]
   861   C1304757:Protein concentration [Laboratory or Test Result]
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "in Buffer R (100mM Tris-HCl,"

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "0.385M L-arginine hydrochloride,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0301556:Arginine hydrochloride [Organic Chemical,Pharmacologic Substance]
   804   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "2mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "10mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "25mM guanidine hydrochloride (GdnHCl)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0120447:Guanidine Hydrochloride [Organic Chemical,Pharmacologic Substance]
   827   C0018320:guanidine [Organic Chemical]
   827   C0120446:Guanidine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   827   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.42: Aggregation was initiated by rapid dilution from 6M GdnHCl, while vortexing into a solution of 37C Buffer R, and was monitored by the increase in turbidity at 400nm. 

Phrase: "Aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "was"

Phrase: "initiated by rapid dilution"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0079240:Dilution [Laboratory Procedure]
   770   C0439831:Rapid [Qualitative Concept]
   770   C1948037:Dilution [Functional Concept]
   737   C1548602:Initiate [Idea or Concept]
   737   C1704686:Initiate [Functional Concept]

Phrase: "from 6M GdnHCl,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0120447:Guanidine Hydrochloride [Organic Chemical,Pharmacologic Substance]
   827   C0018320:guanidine [Organic Chemical]
   827   C0120446:Guanidine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   827   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "while"

Phrase: "vortexing into a solution of 37C Buffer R,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0439648:vortexing [Spatial Concept]
   744   C0724378:vortexing [Organic Chemical,Pharmacologic Substance]
   711 E C2719416:Vortex [Pharmacologic Substance]

Phrase: "and"

Phrase: "was"

Phrase: "monitored by the increase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0442805:Increase [Functional Concept]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]

Phrase: "in turbidity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0301633:Turbidity [Qualitative Concept]
  1000   C2700094:Turbidity [Laboratory Procedure]
   928 E C0311420:Turbid [Qualitative Concept]

Phrase: "at 400nm."
Processing 00000000.tx.43: 26S proteasome, PA700, or 20S proteasome were present at 100nM prior to the addition of F-NBD1 unless otherwise noted. 

Phrase: "26S proteasome,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "PA700,"

Phrase: "or"

Phrase: "20S proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
  1000   C1166808:20S proteasome [Cell Component]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "were"

Phrase: "present at 100nM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "prior to the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of F-NBD1"

Phrase: "unless"

Phrase: "otherwise"

Phrase: "noted."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.44: Assembly of 26S proteasome-- The 26S proteasome was assembled in an ATP-dependent reaction from purified 20S proteasome and PA700 components, as described previously (8). 

Phrase: "Assembly of 26S proteasome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C2752379:26S proteasome assembly [Molecular Function]
   819   C1523886:proteasome assembly [Molecular Function]
   770   C1706853:Assembly [Activity]
   770   C1879748:Assembly [Manufactured Object]

Phrase: "-"

Phrase: "-"

Phrase: "The 26S proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "was"

Phrase: "assembled in an ATP-dependent reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0443286:Reaction [Functional Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
   719   C1706853:Assemble [Activity]

Phrase: "from purified 20S proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
   901   C1166808:20S proteasome [Cell Component]
   827   C1325620:proteasome [Cell Component]
   827   C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "PA700 components,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.45: Assembly conditions contained 2-fold molar excess of 20S proteasome with respect to PA700. 

Phrase: "Assembly conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "2-fold molar excess of 20S proteasome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1979886:Excess [Qualitative Concept]

Phrase: "with respect to PA700."
Processing 00000000.tx.46: Less than 10% of the PA700 was unbound to the proteasome after the assembly reaction. 

Phrase: "Less than 10% of the PA700"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439092:Less Than [Intellectual Product]
           less
   753   C0547044:Less [Qualitative Concept]

Phrase: "was"

Phrase: "unbound to the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]

Phrase: "after the assembly reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.47: Reductive Aggregation of Insulin-- A 2mM stock solution of porcine insulin was prepared in 0.1M potassium phosphate buffer, pH 7.6.

Phrase: "Reductive Aggregation of Insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "-"

Phrase: "-"

Phrase: "A 2mM stock solution of porcine insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037633:Solution [Substance]
   748   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "prepared in 0.1M potassium phosphate buffer,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0071778:potassium phosphate [Inorganic Chemical,Pharmacologic Substance]
   778   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0032821:Potassium [Element, Ion, or Isotope]
   748   C0470296:1M [Quantitative Concept]
   748   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   714   C1521827:Prepare [Functional Concept]

Phrase: "pH 7.6."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.48: Aggregation assays were performed by a modification of previously reported methods (27, 28). 

Phrase: "Aggregation assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed by a modification of previously reported methods"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   770   C1550369:Performed By [Qualitative Concept]
   767   C1709908:Reported By [Group]
   744   C0025663:Methods [Intellectual Product]
   744   C0025664:methods [Intellectual Product]
   744   C0392747:Modification [Functional Concept]
   744   C0449851:Methods [Functional Concept]
   744   C0684224:Reported [Intellectual Product]
   744   C0700287:Reported [Health Care Activity]
   744   C0884358:Performed [Functional Concept]
   744   C1554963:modification [Qualitative Concept]
   744   C3496591:Reported [Clinical Attribute]
   711 E C0871511:METHOD [Intellectual Product]
   711 E C2947996:Perform [Pharmacologic Substance]
   711 E C3273238:Report [Intellectual Product]

Phrase: "(27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.49: Reactions were performed at 37C in a final volume of 250l containing 45mM Tris-HCl, pH 7.8,4mM reduced glutathione, 0.4mM oxidized glutathione, 160M insulin, and concentrations of various proteins as indicated for specific experiments. 

Phrase: "Reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "performed at 37C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in a final volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "of 250l containing 45mM Tris-HCl,"

Phrase: "pH 7.8,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "4mM reduced glutathione,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0034917:Reduced Glutathione [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0392756:Reduced [Qualitative Concept]

Phrase: "0.4mM"

Phrase: "oxidized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0030011:oxidize [Molecular Function]

Phrase: "glutathione,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "160M insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "concentrations of various proteins"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   786   C0427716:Protein concentration [Laboratory Procedure]
   786   C1304757:Protein concentration [Laboratory or Test Result]
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "as"

Phrase: "indicated for specific experiments."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205369:Specific [Qualitative Concept]
   770   C0681814:Experiments [Research Activity]
   770   C1444656:Indicated [Finding]
   770   C1552740:specific [Intellectual Product]
   737 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.50: Aggregation was monitored continuously as an increase in turbidity at 650nm. 

Phrase: "Aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "was"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "continuously as an increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "in turbidity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0301633:Turbidity [Qualitative Concept]
  1000   C2700094:Turbidity [Laboratory Procedure]
   928 E C0311420:Turbid [Qualitative Concept]

Phrase: "at 650nm."
Processing 00000000.tx.51: In independent experiments, the length of the lag phase prior to initial detection of turbidity with insulin alone varied typically from about 300s to about 1100s. 

Phrase: "In independent experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "the length of the lag phase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]

Phrase: "prior to initial detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of turbidity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0301633:Turbidity [Qualitative Concept]
  1000   C2700094:Turbidity [Laboratory Procedure]
   928 E C0311420:Turbid [Qualitative Concept]

Phrase: "with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "varied"

Phrase: "typically from about 300s"

Phrase: "to about 1100s."
Processing 00000000.tx.52: However, within a given experiment, repetitions varied by less than 10%. 

Phrase: "However,"

Phrase: "within a given experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "repetitions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205341:repetitions [Functional Concept]

Phrase: "varied by less"

Phrase: "than 10%."
Processing 00000000.tx.53: All reported results were obtained in at least three to four independent experiments. 

Phrase: "All reported results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained in"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   833   C1301820:Obtained [Functional Concept]
   799 E C1706701:Obtain [Activity]
   761 E C1517378:Gain [Quantitative Concept]
   740 E C0205217:Increased [Quantitative Concept]
   740 E C0439661:Acquired [Temporal Concept]
   740 E C0442805:Increase [Functional Concept]
   740 E C0442808:Increasing [Functional Concept]
   740 E C3245488:acquired [Intellectual Product]

Phrase: "at least three to four independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0681814:Experiments [Research Activity]
   766 E C1706386:Experiment [Conceptual Entity]
   716 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.54: Thermal Aggregation of Citrate Synthase-- Thermal aggregation of citrate synthase (CS) was carried out by adding 150nM (monomer) CS to a solution of 40mM HEPES-KOH, pH 7.5,heated to 43C (29). 

Phrase: "Thermal Aggregation of Citrate Synthase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "--"

Phrase: "Thermal aggregation of citrate synthase (CS)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out by adding 150nM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
   737   C1883712:Add [Functional Concept]

Phrase: "(monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: ")"

Phrase: "CS to a solution of 40mM HEPES-KOH,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C1413745:citrate synthase [Gene or Genome]
   742   C0008857:Citrate [Organic Chemical]
   742   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "heated to 43C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.55: Aggregation was followed by light scattering at 500nm in a PTI fluorometer at right angles with 2nm excitation and 4nm emission slit widths. 

Phrase: "Aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "was"

Phrase: "followed by light scattering"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0332283:Followed by [Temporal Concept]
           followed
   833   C0596837:Light Scattering [Phenomenon or Process]
   770   C0023693:Light [Natural Phenomenon or Process]
   770   C0439742:Scattering [Spatial Concept]
   770   C1306462:Light [Functional Concept]
   770   C1881376:Light [Qualitative Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "at 500nm"

Phrase: "in a PTI fluorometer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0180919:FLUOROMETER [Medical Device]

Phrase: "at right angles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205090:Right [Spatial Concept]
   861   C0205143:angles [Spatial Concept]

Phrase: "with 2nm excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0549255:Excitation [Activity]

Phrase: "and"

Phrase: "4nm emission slit widths."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   779   C0487742:Width [Quantitative Concept]
   729 E C0332464:Wide [Spatial Concept]
Processing 00000000.tx.56: PA700 was present before the addition of CS unless stated otherwise. 

Phrase: "PA700"

Phrase: "was"

Phrase: "present before the addition of CS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "unless"

Phrase: "stated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1301808:stated [Geographic Area]
  1000   C1442792:Stated [Functional Concept]
   966 E C3148680:State [Geographic Area]

Phrase: "otherwise."
Processing 00000000.tx.57: Reactivation of Citrate Synthase-- The reactivation of citrate synthase was monitored in a multi-step assay as described previously (30). 

Phrase: "Reactivation of Citrate Synthase"

Phrase: "-"

Phrase: "-"

Phrase: "The reactivation of citrate synthase"

Phrase: "was"

Phrase: "monitored in a multi-step assay"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C0439064:Multi [Quantitative Concept]
   753   C1261552:Step [Conceptual Entity]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1704379:Step [Functional Concept]
   753   C1705117:Step [Quantitative Concept]
   753   C2825408:Step [Manufactured Object]
   719   C0030695:monitor [Health Care Activity]
   719   C0150369:monitor [Health Care Activity]
   719   C0181904:Monitor [Medical Device]
   719   C0596972:Monitor [Medical Device]
   719   C1521743:Monitor [Professional or Occupational Group]
   719   C1704646:Monitor [Manufactured Object]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.58: In the first step, native CS was denatured in 6M GdnHCl, 50mM Tris-HCl, pH 7.9,2mM dithiothreitol for 1h at room temperature. 

Phrase: "In the first step,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1722730:First Step [Biomedical or Dental Material]
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "native CS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1413745:citrate synthase [Gene or Genome]
   827   C0008857:Citrate [Organic Chemical]
   827   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "denatured in 6M GdnHCl,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0120447:Guanidine Hydrochloride [Organic Chemical,Pharmacologic Substance]
   760   C0018320:guanidine [Organic Chemical]
   760   C0120446:Guanidine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]
   760   C3171719:6M [Quantitative Concept]

Phrase: "50mM Tris-HCl,"

Phrase: "pH 7.9,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "2mM dithiothreitol for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.59: Reactivation of denatured CS was then initiated by dilution into a reactivation buffer containing 100mM Tris-HCl, pH 7.9,2mM dithiothreitol, 10mM KCl and allowed to continue at room temperature. 

Phrase: "Reactivation of denatured CS"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "initiated by dilution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0079240:Dilution [Laboratory Procedure]
   790   C1948037:Dilution [Functional Concept]
   756   C1548602:Initiate [Idea or Concept]
   756   C1704686:Initiate [Functional Concept]

Phrase: "into a reactivation buffer containing 100mM Tris-HCl,"

Phrase: "pH 7.9,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "2mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "10mM KCl"

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "continue at room temperature."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0549178:Continue [Idea or Concept]
   770   C1547703:Room [Spatial Concept]
Processing 00000000.tx.60: Experiments containing ATP (2mM) also included 5mM MgCl2. 

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "ATP"

Phrase: "(2mM"

Phrase: ")"

Phrase: "also included 5mM MgCl2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.61: The activity of the reactivated CS was then assayed spectrophotometrically according to the method of Srere and Kosicki (31) at various time points with freshly prepared oxaloacetic acid and acetyl-CoA. 

Phrase: "The activity of the reactivated CS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C2258114:citrate synthase activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "spectrophotometrically according to the method of Srere"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0680240:according [Social Behavior]
   748   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "Kosicki"

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "at various time points"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "with freshly"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "oxaloacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600556:Oxaloacetic Acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "acetyl-CoA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.62: Experiments done at single time points were assayed after a 45-min reactivation. 

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "done at single time points"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   773   C2348792:Time Point [Temporal Concept]
   760   C0037179:Single [Population Group]
   760   C0040223:Time [Temporal Concept]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C1272695:Done [Qualitative Concept]
   760   C2746065:Done [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   726   C1552961:Point [Quantitative Concept]
   726   C2347617:point [Quantitative Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "were"

Phrase: "assayed after a 45-min reactivation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0702093:/min [Temporal Concept]
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.63: The slope of the initial rate during the linear portion of the progress curve was plotted relative to the activity of mock-treated native CS. 

Phrase: "The slope of the initial rate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0807955:Slope [Quantitative Concept]

Phrase: "during the linear portion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449719:Portion [Spatial Concept]

Phrase: "of the progress curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205134:Curve [Spatial Concept]

Phrase: "was"

Phrase: "plotted"

Phrase: "relative to the activity of mock-treated native CS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0080103:Relative [Family Group]
   739   C0205345:Relative [Qualitative Concept]
   739   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.64: During the time course of the activity assay, which is short relative to the time course of reactivation, no further reactivation occurred. 

Phrase: "During the time course"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0449247:Time course [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C0750729:Course [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "of the activity assay,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0205177:Activity [Functional Concept]
   861   C0243073:assay [Qualitative Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1510438:Assay [Laboratory Procedure]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "which"

Phrase: "is"

Phrase: "short relative to the time course of reactivation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0439564:Relative time [Temporal Concept]
   767   C1547040:*Relative Time [Quantitative Concept]
   744   C0080103:Relative [Family Group]
   744   C0205345:Relative [Qualitative Concept]
   744   C1547039:*Relative [Quantitative Concept]

Phrase: "no further reactivation"

Phrase: "occurred."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.65: To ensure uniformity in initiating the reactivation, denatured CS was added to the reactivation mixture while vortexing. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "uniformity in initiating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   718   C0205375:Uniform [Qualitative Concept]
   718   C1608508:uniform [Quantitative Concept]

Phrase: "the reactivation,"

Phrase: "denatured CS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1413745:citrate synthase [Gene or Genome]
   827   C0008857:Citrate [Organic Chemical]
   827   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "added to the reactivation mixture"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0439962:Mixture [Substance]
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "while"

Phrase: "vortexing."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439648:vortexing [Spatial Concept]
  1000   C0724378:vortexing [Organic Chemical,Pharmacologic Substance]
   966 E C2719416:Vortex [Pharmacologic Substance]
Processing 00000000.tx.66: The fraction of citrate synthase that could be reactivated was reproducible within an experiment but varied between 25and 75% among different citrate synthase preparations. 

Phrase: "The fraction of citrate synthase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1264633:Fraction of [Quantitative Concept]
           Fraction
   760   C1554103:Fraction [Idea or Concept]

Phrase: "that"

Phrase: "could"

Phrase: "be"

Phrase: "reactivated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521123:Reactivated [Functional Concept]

Phrase: "was"

Phrase: "reproducible within an experiment"

Phrase: "but"

Phrase: "varied between 25and 75%"

Phrase: "among different citrate synthase preparations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0455052:Preparation [Health Care Activity]
   779   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.67: Each experiment was repeated multiple times with consistent results obtained with multiple preparations.  

Phrase: "Each experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "multiple times with consistent results"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "obtained with multiple preparations."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0439064:Multiple [Quantitative Concept]
   770   C1301820:Obtained [Functional Concept]
   737   C0455052:Preparation [Health Care Activity]
   737   C1521827:Preparation [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.68: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES PA700, the Regulatory Component of the 26S Proteasome, Inhibits Aggregation of Misfolding F-NBD1-- To understand better the cellular and molecular mechanisms involved in the recognition and processing of misfolded proteins, we studied the interaction of the 26S proteasome with F-NBD1. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "PA700,"

Phrase: "the Regulatory Component of the 26S Proteasome,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "Inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Aggregation of Misfolding F-NBD1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "better"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332272:Better [Qualitative Concept]
   966 E C0205170:Well [Qualitative Concept]
   966 E C3146287:Well [Manufactured Object]

Phrase: "the cellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0007634:Cellular [Cell]
  1000   C0178539:Cellular [Functional Concept]
   928 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in the recognition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0524637:Recognition [Mental Process]
   770   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "processing of misfolded proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0033666:protein processing [Molecular Function]
   770   C1709694:Processing [Activity]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the interaction of the 26S proteasome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1514525:Proteasome Interaction [Molecular Function]
   753   C1704675:Interaction [Functional Concept]

Phrase: "with F-NBD1."
Processing 00000000.tx.69: F-NBD1 is the nucleotide binding domain of CFTR that contains the common cystic fibrosis disease-causing mutation responsible for impaired folding of the full-length CFTR protein (25, 32-34). 

Phrase: "F-NBD1"

Phrase: "is"

Phrase: "the nucleotide binding domain of CFTR"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1148916:nucleotide binding [Molecular Function]
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the common cystic fibrosis disease-causing mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C2985434:Disease-causing Mutation [Cell or Molecular Dysfunction]
   799   C0026882:Mutation [Genetic Function]
   799   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "responsible for impaired folding of the full-length CFTR protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1273518:Responsible [Finding]

Phrase: "(25,"

Phrase: "32-34"

Phrase: ")."
Processing 00000000.tx.70: In refolding experiments, less F-NBD1 reaches the native state than does wild-type NBD1. 

Phrase: "In refolding experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "less F-NBD1"

Phrase: "reaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0596012:Reaches [Finding]
  1000   C2584321:Reach [Organism Function]

Phrase: "the native state than"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0302891:Native [Functional Concept]
   770   C1301808:State [Geographic Area]
   770   C1442792:State [Functional Concept]
   770   C3148680:State [Geographic Area]

Phrase: "does"

Phrase: "wild-type NBD1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.71: A certain fraction, instead, forms large aggregates of misfolded, mutant protein (25, 26, 34). 

Phrase: "A certain fraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "instead,"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "large aggregates of misfolded, mutant protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205418:aggregates [Qualitative Concept]

Phrase: "(25,"

Phrase: "26,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.72: In the cell this misfolding protein is recognized by molecular chaperones (35, 36) and degraded by the ubiquitin-proteasome pathway (37, 38). 

Phrase: "In the cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "this misfolding protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "recognized by molecular chaperones"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0243041:Molecular Chaperones [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Chaperone
   770   C1521991:Molecular [Qualitative Concept]

Phrase: "(35,"

Phrase: "36"

Phrase: ")"

Phrase: "and"

Phrase: "degraded by the ubiquitin-proteasome pathway"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   809   C1519748:Ubiquitin-Proteasomal Pathway [Molecular Function]
   790   C1752727:Proteasome Pathway [Molecular Function]
           Proteasome
   754 E C1523807:proteasomal pathway [Molecular Function]
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1325620:proteasome [Cell Component]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
   753   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(37,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.73: Therefore, F-NBD1 aggregation provides a useful and physiologically relevant in vitro model system for studying interactions of unfolded or misfolded proteins with components of the cellular quality control machinery. 

Phrase: "Therefore,"

Phrase: "F-NBD1 aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332621:Aggregation [Functional Concept]
   827   C0439168:% aggregation [Quantitative Concept]
   755 E C0205418:Aggregate [Qualitative Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a useful"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0042153:use [Functional Concept]
   928   C0457083:Use [Functional Concept]
   928   C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "physiologically relevant in vitro model system for studying interactions of unfolded"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0026339:Model System [Intellectual Product,Research Device]
   756   C3161035:Model System [Intellectual Product]
   738   C0449913:System [Functional Concept]
   738   C1553451:System [Manufactured Object]
   738   C1704459:System [Medical Device]

Phrase: "or"

Phrase: "misfolded proteins with components of the cellular quality control machinery."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   755   C1179435:Component of protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Protein Component
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.74: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.75: 1A, the 26S proteasome completely inhibited aggregation of F-NBD1. 

Phrase: "1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: "the 26S proteasome completely"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1166804:26S proteasome [Cell Component]
   827   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325620:proteasome [Cell Component]
   827   C1552140:26s [Body Part, Organ, or Organ Component]
   827   C1752727:Proteasome [Molecular Function]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "aggregation of F-NBD1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]
Processing 00000000.tx.76: The lack of turbidity observed in the presence of the 26S proteasome was not due to the degradation of F-NBD1 into small, soluble peptides (data not shown). 

Phrase: "The lack of turbidity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "observed in the presence of the 26S proteasome"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1166804:26S proteasome [Cell Component]
   744   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1325620:proteasome [Cell Component]
   744   C1441672:Observed [Functional Concept]
   744   C1552140:26s [Body Part, Organ, or Organ Component]
   744   C1752727:Proteasome [Molecular Function]

Phrase: "was"

Phrase: "not due to the degradation of F-NBD1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   744   C0243125:degradation [Functional Concept]
   744   C0439133:(f) [Intellectual Product]
   744   C0699900:Degradation [Organism Function]
   744   C1518422:Not [Functional Concept]
   744   C1553038:[f] [Quantitative Concept]
   744   C3146286:Due [Idea or Concept]

Phrase: "into small, soluble peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.77: To determine whether either subcomplex of the 26S proteasome was sufficient to inhibit aggregation, 20S proteasome and PA700 were assayed individually for their ability to inhibit the aggregation of F-NBD1. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "either subcomplex of the 26S proteasome"

Phrase: "was"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "aggregation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "20S proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
  1000   C1166808:20S proteasome [Cell Component]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "PA700"

Phrase: "were"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "individually for their ability to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the aggregation of F-NBD1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]
Processing 00000000.tx.78: The 20S proteasome did not affect aggregation, whereas PA700 inhibited aggregation as effectively as the intact 26S proteasome (Fig. 1B). 

Phrase: "The 20S proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
  1000   C1166808:20S proteasome [Cell Component]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "aggregation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "whereas"

Phrase: "PA700"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "as"

Phrase: "effectively as the intact 26S proteasome"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1166804:26S proteasome [Cell Component]
   753   C0205266:Intact [Qualitative Concept]
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1325620:proteasome [Cell Component]
   753   C1552140:26s [Body Part, Organ, or Organ Component]
   753   C1554187:Intact [Idea or Concept]
   753   C1752727:Proteasome [Molecular Function]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.79: These data demonstrate that the inhibitory activity of the 26S proteasome can be attributed to PA700. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the inhibitory activity of the 26S proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C1622946:proteasome activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "attributed to PA700."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0449234:Attribute [Idea or Concept]
   756   C1704772:Attribute [Conceptual Entity]
   756   C1882133:Attribute [Qualitative Concept]
Processing 00000000.tx.80: View larger version (20K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.81: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.82: Components of the proteasomal machinery inhibit CFTR F-NBD1 aggregation. 

Phrase: "Components of the proteasomal machinery"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0449432:Components [Manufactured Object]
   726 E C1705248:Component [Conceptual Entity]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "CFTR F-NBD1 aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332621:Aggregation [Functional Concept]
   812   C0439168:% aggregation [Quantitative Concept]
   741 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.83: GdnHCl-denatured F-NBD1 was diluted into Buffer R under conditions (2M F-NBD1, 37C) where folding to the native state is disfavored and F-NBD1 aggregates. 

Phrase: "GdnHCl-denatured F-NBD1"

Phrase: "was"

Phrase: "diluted into Buffer R"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0205090:R- [Spatial Concept]
   770   C0684010:R. [Professional or Occupational Group]
   770   C2603358:R' [Clinical Attribute]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]

Phrase: "under conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(2M F-NBD1,"

Phrase: "37C"

Phrase: ")"

Phrase: "where folding to the native state"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "disfavored"

Phrase: "and"

Phrase: "F-NBD1 aggregates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205418:aggregates [Qualitative Concept]
Processing 00000000.tx.84: A, aggregation in the absence or presence of 100nM 26S proteasome (+26 S). 

Phrase: "A,"

Phrase: "aggregation in the absence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "or"

Phrase: "presence of 100nM 26S proteasome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(+26"

Phrase: "S)."
Processing 00000000.tx.85: B: Aggregation of F-NBD1, F-NBD1 with 100nM 20S proteasome (+20 S), or F-NBD1 with 100nM PA700 (+PA700). 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Aggregation of F-NBD1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "F-NBD1 with 100nM 20S proteasome"

Phrase: "(+20"

Phrase: "S)"

Phrase: ","

Phrase: "or"

Phrase: "F-NBD1 with 100nM PA700"

Phrase: "(+PA700"

Phrase: ")."
Processing 00000000.tx.86: PA700 Inhibits the Aggregation of Other Misfolding Proteins-- To determine whether the ability of PA700 to interact with the non-native conformation of F-NBD1 is a general property, analogous experiments were conducted with two additional proteins whose misfolding can be initiated under different conditions. 

Phrase: "PA700"

Phrase: "Inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the Aggregation of Other Misfolding Proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the ability of PA700 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "interact with the non-native conformation of F-NBD1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   742   C0026377:Conformation [Spatial Concept]
   742   C0302891:Native [Functional Concept]
   742   C0439133:(f) [Intellectual Product]
   742   C1518422:Non [Functional Concept]
   742   C1553038:[f] [Quantitative Concept]

Phrase: "is"

Phrase: "a general property,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0871161:Property [Qualitative Concept]
   861   C1882134:Property [Conceptual Entity]
   861   C2347695:Property [Entity]

Phrase: "analogous experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "conducted with two additional proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205448:Two [Quantitative Concept]
   760   C1524062:Additional [Functional Concept]
   726   C0004927:Conduct [Individual Behavior]

Phrase: "whose misfolding"

Phrase: "can"

Phrase: "be"

Phrase: "initiated under different conditions."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1705242:Different [Qualitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1548602:Initiate [Idea or Concept]
   737   C1704686:Initiate [Functional Concept]
   737   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.87: Insulin is composed of two polypeptide chains, A and B, linked by two disulfide bonds. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "composed of two polypeptide chains,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205448:Two [Quantitative Concept]
   760   C0337112:chains [Manufactured Object]
   760   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   760   C1524075:Chains [Idea or Concept]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "linked by two disulfide bonds."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C1511997:Disulfide Bond [Amino Acid Sequence]
   760   C0012771:disulfide [Chemical Viewed Structurally]
   760   C0205448:Two [Quantitative Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
Processing 00000000.tx.88: Upon reduction of the disulfides, the chains separate, and the B chain aggregates (27, 28). 

Phrase: "Upon reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "of the disulfides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012771:Disulfides [Chemical Viewed Structurally]

Phrase: "the chains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337112:chains [Manufactured Object]
  1000   C1524075:Chains [Idea or Concept]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: ","

Phrase: "and"

Phrase: "the B chain aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205418:aggregates [Qualitative Concept]

Phrase: "(27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.89: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.90: 2, PA700 inhibited this aggregation as effectively as the 26S proteasome, whereas the 20S proteasome had no inhibitory effect. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "PA700"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "this aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "as"

Phrase: "effectively as the 26S proteasome,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1166804:26S proteasome [Cell Component]
   760   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1325620:proteasome [Cell Component]
   760   C1552140:26s [Body Part, Organ, or Organ Component]
   760   C1752727:Proteasome [Molecular Function]

Phrase: "whereas"

Phrase: "the 20S proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
  1000   C1166808:20S proteasome [Cell Component]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "had"

Phrase: "no inhibitory effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.91: View larger version (18K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.92: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.93: PA700 inhibits the aggregation of insulin. 

Phrase: "PA700"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the aggregation of insulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]
Processing 00000000.tx.94: Aggregation was initiated by dilution of native insulin (160M) into reducing buffer. 

Phrase: "Aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "was"

Phrase: "initiated by dilution of native insulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0079240:Dilution [Laboratory Procedure]
   753   C0302891:Native [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1948037:Dilution [Functional Concept]
   719   C1548602:Initiate [Idea or Concept]
   719   C1704686:Initiate [Functional Concept]

Phrase: "(160M"

Phrase: ")"

Phrase: "into reducing buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.95: A, aggregation of insulin alone, insulin with 300nM 20S proteasome (+20 S), insulin with 300nM 20S, 160nM PA700-assembled 26S proteasome (+26 S), or insulin with 160nM PA700 (+PA700). 

Phrase: "A,"

Phrase: "aggregation of insulin alone, insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "with 300nM 20S proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
   901   C1166808:20S proteasome [Cell Component]
   827   C1325620:proteasome [Cell Component]
   827   C1752727:Proteasome [Molecular Function]

Phrase: "(+20"

Phrase: "S)"

Phrase: ","

Phrase: "insulin with 300nM 20S,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "160nM PA700-assembled 26S proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1166804:26S proteasome [Cell Component]
   804   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1325620:proteasome [Cell Component]
   804   C1552140:26s [Body Part, Organ, or Organ Component]
   804   C1752727:Proteasome [Molecular Function]

Phrase: "(+26"

Phrase: "S)"

Phrase: ","

Phrase: "or"

Phrase: "insulin with 160nM PA700"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(+PA700"

Phrase: ")."
Processing 00000000.tx.96: B, aggregation of insulin alone, insulin with 300nM modulator (+Modulator), or insulin with 300nM PA28 (+PA28). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "aggregation of insulin alone, insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "with 300nM modulator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709060:Modulator [Manufactured Object]

Phrase: "(+Modulator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709060:Modulator [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "insulin with 300nM PA28"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(+PA28"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1166811:PA28 [Cell Component]

Phrase: ")."
Processing 00000000.tx.97: C, aggregation of insulin with no PA700, 50nM PA700 (3200:1), 100nM PA700 (1600:1), 200nM PA700 (800:1), or 400nM PA700 (400:1). 

Phrase: "C,"

Phrase: "aggregation of insulin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332621:Aggregation [Functional Concept]
   790   C0439168:% aggregation [Quantitative Concept]
   718 E C0205418:Aggregate [Qualitative Concept]

Phrase: "with no PA700,"

Phrase: "50nM PA700"

Phrase: "(3200"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "100nM PA700"

Phrase: "(1600"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "200nM PA700"

Phrase: "(800"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "400nM PA700"

Phrase: "(400"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.98: To extend further the generality of this effect, we tested the ability of PA700 to inhibit the aggregation of thermally denatured citrate synthase, a protein commonly utilized for studying chaperone activity (29, 30, 39). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "the generality of this effect,"

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the ability of PA700 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the aggregation of thermally denatured citrate synthase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332621:Aggregation [Functional Concept]
   748   C0439168:% aggregation [Quantitative Concept]

Phrase: "a protein commonly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "utilized for studying chaperone activity"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C1149552:chaperone activity [Molecular Function]
   781   C2348552:Study Activity [Research Activity]
   760   C0205177:Activity [Functional Concept]
   760   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
   745 E C2347179:Active Study [Functional Concept]
   726   C0557651:Study [Manufactured Object]
   726   C2603343:Study [Research Activity]

Phrase: "(29,"

Phrase: "30,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.99: Native citrate synthase is a homodimer; 

Phrase: "Native citrate synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1413745:citrate synthase [Gene or Genome]
   827   C0008857:Citrate [Organic Chemical]
   827   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "a homodimer"

Phrase: ";"
Processing 00000000.tx.100: when heated to 43C, the population of partially folded conformations of citrate synthase increases, leading to aggregation. 

Phrase: "when"

Phrase: "heated to 43C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "the population of partially folded conformations of citrate synthase increases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0032659:Population [Quantitative Concept]
   739   C1257890:Population [Population Group]

Phrase: "leading to aggregation."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   790   C0332152:Leading [Temporal Concept]
   790   C0332621:Aggregation [Functional Concept]
   790   C0439168:% aggregation [Quantitative Concept]
   790   C1522538:Leading [Functional Concept]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]
   718 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.101: As with the other tested proteins, citrate synthase aggregation was inhibited by PA700 at low molar ratios (Fig. 3). 

Phrase: "As with the"

Phrase: "other tested proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0788300:test protein [Medical Device]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "citrate synthase aggregation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0332621:Aggregation [Functional Concept]
   827   C0439168:% aggregation [Quantitative Concept]
   755 E C0205418:Aggregate [Qualitative Concept]
   734   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1413745:citrate synthase [Gene or Genome]

Phrase: "was"

Phrase: "inhibited by PA700"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "at low molar ratios"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C2825550:Molar Ratio [Quantitative Concept]
   827   C0456603:Ratios [Quantitative Concept]
   827   C1610540:*Ratios [Quantitative Concept]
   793 E C1547037:Ratio [Intellectual Product]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.102: PA700 increased the lag period of citrate synthase aggregation in a manner similar to its effect on insulin. 

Phrase: "PA700"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the lag period of citrate synthase aggregation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439531:/period [Temporal Concept]
   748   C1416797:Lag [Gene or Genome]
   748   C1948053:Period [Temporal Concept]

Phrase: "in a manner"

Phrase: "similar to its effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "on insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.103: Together, these data demonstrate that PA700 interacts with non-native forms of a variety of proteins. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that PA700"

Phrase: "interacts with non-native forms of a variety of proteins."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   741   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0302891:Native [Functional Concept]
   739   C0348078:forms [Qualitative Concept]
   739   C0376315:Forms [Manufactured Object]
   739   C1518422:Non [Functional Concept]
   739   C1883525:Variety [Conceptual Entity]
   739   C2346866:Variety [Conceptual Entity]
   706 E C1522492:Form [Functional Concept]
Processing 00000000.tx.104: View larger version (20K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.105: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.106: PA700 inhibits the thermal aggregation of citrate synthase. 

Phrase: "PA700"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the thermal aggregation of citrate synthase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]
Processing 00000000.tx.107: Native citrate synthase (150nM) was heated to 43C either alone or in the presence of 0.9nM PA700 (160:1), 1.9nM PA700 (80:1), or 5nM PA700 (30:1). 

Phrase: "Native citrate synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1413745:citrate synthase [Gene or Genome]
   827   C0008857:Citrate [Organic Chemical]
   827   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "(150nM"

Phrase: ")"

Phrase: "was"

Phrase: "heated to 43C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "either alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "or in the presence of 0.9nM PA700"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(160"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "1.9nM PA700"

Phrase: "(80"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "5nM PA700"

Phrase: "(30"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.108: a.u., arbitrary units. 

Phrase: "a.u.,"

Phrase: "arbitrary units."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   966   C0439183:Arbitrary unit [Quantitative Concept]
   861   C0439148:Units [Quantitative Concept]
   861   C1264693:*Arbitrary [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.109: The ability of PA700 to inhibit aggregation is specific to PA700 and is not a property of either of two related multiprotein proteasome regulator complexes. 

Phrase: "The ability of PA700 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "is"

Phrase: "specific to PA700"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a property of either of two related multiprotein proteasome regulator complexes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0871161:Property [Qualitative Concept]
   738   C1882134:Property [Conceptual Entity]
   738   C2347695:Property [Entity]
Processing 00000000.tx.110: First, a protein complex, termed "modulator," consisting of two of the ATPase subunits found in PA700 and a third novel protein not found in PA700, enhances PA700-dependent activation of the proteasome (21) but was not effective at inhibiting the aggregation of insulin (Fig. 2B). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "a protein complex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1523872:protein complex [Cell Component]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "termed ""modulator,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709060:Modulator [Manufactured Object]

Phrase: """"

Phrase: "consisting of two of the ATPase subunits"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205448:Two [Quantitative Concept]
   748   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   714   C0332529:CONSIST [Qualitative Concept]
   714   C1711351:Subunit [Quantitative Concept]

Phrase: "found in PA700"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "a third novel protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "found in PA700,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "PA700-dependent activation of the proteasome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "(21"

Phrase: ")"

Phrase: "but"

Phrase: "was"

Phrase: "not effective at inhibiting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280519:effective [Qualitative Concept]
   770   C1704419:Effective [Qualitative Concept]

Phrase: "the aggregation of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.111: Second, the proteasome activator PA28 (23), which is known to associate with the 20S proteasome, did not inhibit the aggregation of insulin (Fig. 2B). 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "the proteasome activator PA28"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1166811:PA28 [Cell Component]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "associate with the 20S proteasome,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
   806   C1166808:20S proteasome [Cell Component]
   760   C0750490:Associate [Idea or Concept]
   760   C1325620:proteasome [Cell Component]
   760   C1552134:20s [Body Part, Organ, or Organ Component]
   760   C1706221:Associate [Professional or Occupational Group]
   760   C1752727:Proteasome [Molecular Function]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the aggregation of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.112: In addition, PA700 that has been heat-treated for 15min at 75C is no longer effective in retarding the aggregation of insulin (data not shown). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "PA700"

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "heat-treated for 15min"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0018837:Heat [Natural Phenomenon or Process]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "at 75C"

Phrase: "is"

Phrase: "no longer effective in retarding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280519:effective [Qualitative Concept]
   760   C1704419:Effective [Qualitative Concept]

Phrase: "the aggregation of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.113: These data provide further evidence for specificity of the PA700-dependent inhibition of aggregation. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "further evidence for specificity of the PA700-dependent inhibition of aggregation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.114: The extent of inhibition of insulin aggregation was directly proportional to the concentration of PA700; 

Phrase: "The extent of inhibition of insulin aggregation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439792:Extent [Spatial Concept]

Phrase: "was"

Phrase: "directly proportional to the concentration of PA700"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205351:Proportional [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.115: but surprisingly, inhibition occurred at PA700 concentrations 1000-fold less than those of the substrate insulin. 

Phrase: "but"

Phrase: "surprisingly,"

Phrase: "inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "occurred at PA700 concentrations 1000-fold less"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0086045:Concentrations [Mental Process]
   748   C0332462:Fold [Spatial Concept]
   748   C1709305:Occurred [Activity]
   748   C1880834:FOLD [Phenomenon or Process]
   714 E C1446561:Concentration [Quantitative Concept]
   714 E C2745955:OCCUR [Temporal Concept]

Phrase: "than those"

Phrase: "of the substrate insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.116: Furthermore, PA700 increased the lag time of insulin aggregation in a concentration-dependent manner (Fig. 2C). 

Phrase: "Furthermore,"

Phrase: "PA700"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the lag time of insulin aggregation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0040223:Time [Temporal Concept]
   753   C1416797:Lag [Gene or Genome]
   753   C3541383:Time [Temporal Concept]

Phrase: "in a concentration-dependent manner"

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.117: In contrast, simple reduction of the insulin concentration in the absence of PA700 reduced the rate of aggregation but did not have a significant effect on the lag phase in this concentration range (data not shown). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "simple reduction of the insulin concentration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of PA700"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the rate of aggregation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "but"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "a significant effect on the lag phase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "in this concentration range"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.118: These results suggest that PA700 interacts with a subpopulation or with a transient intermediate of misfolding insulin which is particularly prone to aggregation (see "Discussion"). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that PA700"

Phrase: "interacts with a subpopulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1257890:Subpopulation [Population Group]

Phrase: "or with a transient intermediate of misfolding insulin"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0040704:Transient [Population Group]
   744   C0205103:Intermediate [Spatial Concept]
   744   C0205374:Transient [Temporal Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1550465:intermediate [Idea or Concept]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "which"

Phrase: "is"

Phrase: "particularly prone to aggregation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033422:Prone [Spatial Concept]

Phrase: "(see ""Discussion"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557061:Discussion [Therapeutic or Preventive Procedure]
   861   C2584313:Discussion [Social Behavior]

Phrase: ")."
Processing 00000000.tx.119: PA700 Promotes Refolding of Misfolding Citrate Synthase-- In addition to inhibiting aggregation of misfolding proteins, many molecular chaperones promote refolding of these proteins to native structures. 

Phrase: "PA700"

Phrase: "Promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "Refolding of Misfolding Citrate Synthase"

Phrase: "-"

Phrase: "-"

Phrase: "In addition to inhibiting aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]

Phrase: "of misfolding proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "many molecular chaperones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243041:Molecular Chaperones [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Chaperone

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "refolding of these proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C1158944:Protein Refolding [Molecular Function]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to native structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]
Processing 00000000.tx.120: Therefore, we tested the ability of PA700 to promote reactivation of chemically denatured citrate synthase. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the ability of PA700 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "reactivation of chemically denatured citrate synthase."
Processing 00000000.tx.121: Native citrate synthase was first denatured with 6M guanidinium hydrochloride, and then refolding was initiated by rapid dilution into a nondenaturing buffer. 

Phrase: "Native citrate synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1413745:citrate synthase [Gene or Genome]
   827   C0008857:Citrate [Organic Chemical]
   827   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "denatured with 6M guanidinium hydrochloride,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0120446:Guanidinium [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]
   760   C3171719:6M [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "refolding"

Phrase: "was"

Phrase: "initiated by rapid dilution"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0079240:Dilution [Laboratory Procedure]
   770   C0439831:Rapid [Qualitative Concept]
   770   C1948037:Dilution [Functional Concept]
   737   C1548602:Initiate [Idea or Concept]
   737   C1704686:Initiate [Functional Concept]

Phrase: "into a nondenaturing buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.122: The restoration of native structure was monitored by the recovery of enzymatic activity. 

Phrase: "The restoration of native structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C0678689:restoration of structure [Organism Function]
   760   C0449982:Restoration [Intellectual Product]

Phrase: "was"

Phrase: "monitored by the recovery of enzymatic activity."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C2267219:Enzymatic Activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0237820:Recovery [Activity]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1555688:recovery [Idea or Concept]
   748   C1561536:*Activity [Idea or Concept]
   748   C2004454:Recovery [Organism Function]
   714   C0030695:monitor [Health Care Activity]
   714   C0150369:monitor [Health Care Activity]
   714   C0181904:Monitor [Medical Device]
   714   C0596972:Monitor [Medical Device]
   714   C1521743:Monitor [Professional or Occupational Group]
   714   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.123: Under these conditions, denatured citrate synthase refolds poorly in the absence of chaperones (Fig. 4 and Refs. 29, 30, and 39). 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "denatured citrate synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1413745:citrate synthase [Gene or Genome]
   827   C0008857:Citrate [Organic Chemical]
   827   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "refolds"

Phrase: "poorly in the absence of chaperones"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205169:Poorly [Qualitative Concept]
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]
   719   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "Refs. 29,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: "30,"

Phrase: "and"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.124: However, in the presence of PA700, enzymatic activity was recovered in both a time-dependent and PA700 concentration-dependent fashion (Fig. 4). 

Phrase: "However,"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of PA700,"

Phrase: "enzymatic activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2267219:Enzymatic Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "recovered in both"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0521108:recovered [Qualitative Concept]
   756 E C2004454:recover [Organism Function]

Phrase: "a time-dependent"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0040223:Time [Temporal Concept]
   861   C0851827:Dependent [Qualitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "PA700 concentration-dependent fashion"

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.125: These effects were achieved at the same low molar ratios required for inhibition of aggregation. 

Phrase: "These effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "achieved at the same low molar ratios"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   762   C2825550:Molar Ratio [Quantitative Concept]
   748   C0026367:Molar [Body Part, Organ, or Organ Component]
   748   C0205251:low [Qualitative Concept]
   748   C0445247:Same [Qualitative Concept]
   748   C0456603:Ratios [Quantitative Concept]
   748   C1299352:Low [Qualitative Concept]
   748   C1550472:low [Idea or Concept]
   748   C1610540:*Ratios [Quantitative Concept]
   714 E C1547037:Ratio [Intellectual Product]

Phrase: "required for inhibition of aggregation."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]
   760   C1514873:Required [Functional Concept]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]
Processing 00000000.tx.126: Thus, by inhibiting aggregation of misfolded citrate synthase, PA700 promotes its refolding. 

Phrase: "Thus,"

Phrase: "by inhibiting aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]

Phrase: "of misfolded citrate synthase,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1413745:citrate synthase [Gene or Genome]
   827   C0008857:Citrate [Organic Chemical]
   827   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "PA700"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "its refolding."
Processing 00000000.tx.127: View larger version (12K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.128: 4.  

Phrase: "4."
Processing 00000000.tx.129: PA700 reactivates citrate synthase. 

Phrase: "PA700"

Phrase: "reactivates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521123:reactivate [Functional Concept]

Phrase: "citrate synthase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413745:citrate synthase [Gene or Genome]
   861   C0008857:Citrate [Organic Chemical]
   861   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.130: GdnHCl-denatured citrate synthase was diluted into refolding conditions, and the formation of active, native protein was monitored. 

Phrase: "GdnHCl-denatured citrate synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1413745:citrate synthase [Gene or Genome]
   804   C0008857:Citrate [Organic Chemical]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "diluted into refolding conditions,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]

Phrase: "and"

Phrase: "the formation of active, native protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597295:protein formation [Molecular Function]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "monitored."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.131: A, time course of CS reactivation in the absence (open squares) or presence (closed circles) of 300nM PA700. 

Phrase: "A,"

Phrase: "time course of CS reactivation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0449247:Time course [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0750729:Course [Temporal Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "(open squares"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205120:Square [Spatial Concept]
   827   C1552595:Square [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "(closed circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "of 300nM PA700."
Processing 00000000.tx.132: B, CS reactivation at 45min with increasing concentrations of PA700. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "CS reactivation at 45min"

Phrase: "with increasing concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of PA700."
Processing 00000000.tx.133: PA700 Does Not Depend on ATP to Inhibit Aggregation or Promote Refolding of Misfolded Proteins-- Many well characterized molecular chaperones utilize ATP to modulate the rate of substrate turnover as they inhibit aggregation and/or promote refolding (40-46). 

Phrase: "PA700"

Phrase: "Does"

Phrase: "Not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "Depend on ATP to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0725813:depend [Medical Device]

Phrase: "Inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "or"

Phrase: "Promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "Refolding of Misfolded Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   802   C1158944:Protein Refolding [Molecular Function]

Phrase: "-"

Phrase: "-"

Phrase: "Many well characterized molecular chaperones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243041:Molecular Chaperones [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Chaperone

Phrase: "utilize"

Phrase: "ATP to"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the rate of substrate turnover"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "as"

Phrase: "they"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and/or"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "refolding"

Phrase: "(40-46"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.134: To determine whether PA700, a known ATPase (16, 47), requires ATP for these activities, we repeated the described assays in the presence and absence of Mg2+ or ATP. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "PA700,"

Phrase: "a known ATPase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(16,"

Phrase: "47"

Phrase: ")"

Phrase: ","

Phrase: "requires"

Phrase: "ATP for these activities,"

Phrase: "we"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "the described assays in the presence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "absence of Mg2+"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "ATP."
Processing 00000000.tx.135: Mg2+ or ATP had no significant effect on the ability of PA700 to inhibit the aggregation of F-NBD1, insulin, or citrate synthase (Fig. 5, A-C). 

Phrase: "Mg2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417500:MG2 [Gene or Genome]
  1000   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "or"

Phrase: "ATP"

Phrase: "had"

Phrase: "no significant effect on the ability of PA700 to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1301751:No effect [Qualitative Concept]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the aggregation of F-NBD1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "citrate synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413745:citrate synthase [Gene or Genome]
   861   C0008857:Citrate [Organic Chemical]
   861   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A-C)."
Processing 00000000.tx.136: In addition, neither ADP nor the nonhydrolyzable analog ATPS influenced the results. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "neither ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]

Phrase: "nor"

Phrase: "the nonhydrolyzable analog ATPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004482:atps [Organic Chemical,Pharmacologic Substance]

Phrase: "influenced"

Phrase: "the results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.137: ATP also did not affect the ability of PA700 to reactivate citrate synthase (Fig. 5E). 

Phrase: "ATP also"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the ability of PA700 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "reactivate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521123:reactivate [Functional Concept]

Phrase: "citrate synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413745:citrate synthase [Gene or Genome]
   861   C0008857:Citrate [Organic Chemical]
   861   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig. 5E"

Phrase: ")."
Processing 00000000.tx.138: To confirm this result, PA700 was treated with N-ethylmaleimide (NEM), which abolishes its ATPase activity (16). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "this result,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "PA700"

Phrase: "was"

Phrase: "treated with N-ethylmaleimide (NEM),"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0015101:Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "which"

Phrase: "abolishes"

Phrase: "its ATPase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1148926:ATPase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.139: NEM-treated PA700 effectively inhibited the aggregation of insulin (Fig. 5D) and promoted the reactivation of citrate synthase (Fig. 5E). 

Phrase: "NEM-treated PA700 effectively"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the aggregation of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "(Fig. 5D"

Phrase: ")"

Phrase: "and"

Phrase: "promoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "the reactivation of citrate synthase"

Phrase: "(Fig. 5E"

Phrase: ")."
Processing 00000000.tx.140: These data indicate that the interaction of PA700 with non-native protein substrates does not depend upon ATP. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that"

Phrase: "the interaction of PA700"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with non-native protein substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1710236:Substrate [Manufactured Object]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "depend upon ATP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0725813:depend [Medical Device]
Processing 00000000.tx.141: View larger version (27K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.142: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.143: ATP is not required for PA700 inhibition of aggregation or the reactivation of CS. 

Phrase: "ATP"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "required for PA700 inhibition of aggregation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]
   753   C1514873:Required [Functional Concept]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "or"

Phrase: "the reactivation of CS."
Processing 00000000.tx.144: A, F-NBD1 (2M) was aggregated at 37C as in Fig. 

Phrase: "A,"

Phrase: "F-NBD1"

Phrase: "(2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3171718:2M [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "aggregated at 37C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0332621:Aggregated [Functional Concept]
   756 E C0205418:Aggregate [Qualitative Concept]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.145: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.146: Aggregation was either with no PA700, 100nM PA700 (+PA700), or 100nM PA700, 20mM MgCl2, 2mM ATP (+PA700 (+ATP)). 

Phrase: "Aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "was"

Phrase: "either with no PA700,"

Phrase: "100nM PA700"

Phrase: "(+PA700"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "100nM PA700,"

Phrase: "20mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "2mM ATP"

Phrase: "(+PA700"

Phrase: "(+ATP"

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.147: B, insulin (160M) was aggregated under reducing conditions as in Fig. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(160M"

Phrase: ")"

Phrase: "was"

Phrase: "aggregated under reducing conditions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0332621:Aggregated [Functional Concept]
   770   C0392756:Reducing [Qualitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737 E C0205418:Aggregate [Qualitative Concept]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.148: 2A. 

Phrase: "2A."
Processing 00000000.tx.149: Reactions contained insulin, insulin+160nM PA700 (+PA700), or insulin+3.6mM MgCl2, 800M ATP, 160nM PA700 (+PA700 (+ATP)). 

Phrase: "Reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin+160nM PA700"

Phrase: "(+PA700"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "insulin+3.6mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "800M ATP,"

Phrase: "160nM PA700"

Phrase: "(+PA700"

Phrase: "(+ATP"

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.150: C, CS (150nM) thermal aggregation was carried out with CS, CS+7.5nM PA700 (+PA700), CS+200M ATP, 7.5nM PA700 (+PA700 (+ATP)), or CS+200M ADP, 7.5nM PA700 (+PA700 (+ADP)). 

Phrase: "C,"

Phrase: "CS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413745:citrate synthase [Gene or Genome]
   861   C0008857:Citrate [Organic Chemical]
   861   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "(150nM"

Phrase: ")"

Phrase: "thermal aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with CS,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1413745:citrate synthase [Gene or Genome]
   770   C0008857:Citrate [Organic Chemical]
   770   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]

Phrase: "CS+7.5nM PA700"

Phrase: "(+PA700"

Phrase: ")"

Phrase: ","

Phrase: "CS+200M ATP,"

Phrase: "7.5nM PA700"

Phrase: "(+PA700"

Phrase: "(+ATP"

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "CS+200M ADP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0523452:ADP [Laboratory Procedure]

Phrase: "7.5nM PA700"

Phrase: "(+PA700"

Phrase: "(+ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.151: MgCl2 (1mM) was present in all reactions. 

Phrase: "MgCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(1mM"

Phrase: ")"

Phrase: "was"

Phrase: "present in all reactions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
Processing 00000000.tx.152: D, insulin (160M) aggregation was initiated with no additions, with 215nM PA700 (+PA700) or with 215nM NEM-treated PA700 (+PA700NEM). 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(160M"

Phrase: ")"

Phrase: "aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "was"

Phrase: "initiated with no additions,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1548602:Initiate [Idea or Concept]
   737   C1704686:Initiate [Functional Concept]
   737   C1883712:Addition [Functional Concept]

Phrase: "with 215nM PA700"

Phrase: "(+PA700"

Phrase: ")"

Phrase: "or with 215nM NEM-treated PA700"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   774   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0015101:Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C1522326:Treated [Functional Concept]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "(+PA700NEM"

Phrase: ")."
Processing 00000000.tx.153: E, Gdn-HCl-denatured CS (150nM) was reactivated either alone or with the addition of 2mM ATP; 

Phrase: "E,"

Phrase: "Gdn-HCl-denatured CS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1413745:citrate synthase [Gene or Genome]
   804   C0008857:Citrate [Organic Chemical]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "(150nM"

Phrase: ")"

Phrase: "was"

Phrase: "reactivated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521123:Reactivated [Functional Concept]

Phrase: "either alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "or with the addition of 2mM ATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1883712:Addition [Functional Concept]

Phrase: ";"
Processing 00000000.tx.154: 2mM ATPS; 

Phrase: "2mM ATPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004482:atps [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.155: 300nM PA700; 

Phrase: "300nM PA700"

Phrase: ";"
Processing 00000000.tx.156: 300nM PA700, 2mM ATP; 

Phrase: "300nM PA700,"

Phrase: "2mM ATP"

Phrase: ";"
Processing 00000000.tx.157: 300nM NEM-treated PA700, 2mM ATP; 

Phrase: "300nM NEM-treated PA700,"

Phrase: "2mM ATP"

Phrase: ";"
Processing 00000000.tx.158: or 300nM PA700, 2mM ATPS. 

Phrase: "or"

Phrase: "300nM PA700,"

Phrase: "2mM ATPS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004482:atps [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.159: All reactions contained 5mM MgCl2. 

Phrase: "All reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "5mM MgCl2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.160: Bars represent the average of three experiments. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the average of three experiments."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1510992:Average [Quantitative Concept]
   760   C2825518:AVERAGE [Quantitative Concept]
Processing 00000000.tx.161: PA700 Recognizes a Subset of Non-native Substrate Conformations-- The substoichiometric PA700:substrate ratios required for inhibition of aggregation and promotion of refolding and the progressively increased delay in onset of aggregation in the presence of PA700 suggest that PA700 interacts with a subpopulation of non-native conformations. 

Phrase: "PA700"

Phrase: "Recognizes"

Phrase: "a Subset of Non-native Substrate Conformations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1515021:Subset [Classification]

Phrase: "-"

Phrase: "-"

Phrase: "The substoichiometric PA700"

Phrase: ":"

Phrase: "substrate ratios"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "required for inhibition of aggregation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]
   760   C1514873:Required [Functional Concept]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "promotion of refolding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033414:Promotion [Activity]

Phrase: "and"

Phrase: "the progressively increased delay in onset of aggregation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205421:Delay [Temporal Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of PA700"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that PA700"

Phrase: "interacts with a subpopulation of non-native conformations."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0302891:Native [Functional Concept]
   744   C1257890:Subpopulation [Population Group]
   744   C1518422:Non [Functional Concept]
   711   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.162: To test this possibility further, PA700 was added to either the citrate synthase aggregation assay or reactivation assay after each process had begun. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this possibility further,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "PA700"

Phrase: "was"

Phrase: "added to either"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "the citrate synthase aggregation assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "or"

Phrase: "reactivation assay after each process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C1510438:Assay [Laboratory Procedure]

Phrase: "had"

Phrase: "begun."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]
Processing 00000000.tx.163: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.164: 6, PA700 remained effective at inhibiting the thermal aggregation of initially folded citrate synthase when added 20s after the initiation of misfolding. 

Phrase: "6,"

Phrase: "PA700"

Phrase: "remained"

Phrase: "effective at inhibiting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280519:effective [Qualitative Concept]
   790   C1704419:Effective [Qualitative Concept]

Phrase: "the thermal aggregation of initially folded citrate synthase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332621:Aggregation [Functional Concept]
   744   C0439168:% aggregation [Quantitative Concept]

Phrase: "when"

Phrase: "added 20s after the initiation of misfolding."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1552134:20s [Body Part, Organ, or Organ Component]
Processing 00000000.tx.165: However, PA700 was progressively less effective at inhibiting aggregation when addition was delayed for longer times. 

Phrase: "However,"

Phrase: "PA700"

Phrase: "was"

Phrase: "progressively less effective at inhibiting aggregation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280519:effective [Qualitative Concept]
   753   C1704419:Effective [Qualitative Concept]

Phrase: "when"

Phrase: "addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "was"

Phrase: "delayed for longer times."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   802   C0522486:delayed time [Temporal Concept]
   770   C0040223:times [Temporal Concept]
   770   C0205421:Delayed [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   770   C3272602:Delayed [Qualitative Concept]
   737   C0205166:Long [Qualitative Concept]
   737   C1706317:Long [Qualitative Concept]
   737 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.166: These results cannot be explained by simple stoichiometric binding of PA700 because of the large excess of unfolded monomer and, thus, imply that PA700 may act on a species critical for initiation of aggregation. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "cannot"

Phrase: "be"

Phrase: "explained by simple stoichiometric binding of PA700"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205352:Simple [Qualitative Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "because of the large excess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979886:Excess [Qualitative Concept]

Phrase: "of unfolded monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "and"

Phrase: ","

Phrase: "thus,"

Phrase: "imply"

Phrase: "that PA700"

Phrase: "may"

Phrase: "act on a species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079613:ACT [Therapeutic or Preventive Procedure]
   770   C1705920:Species [Conceptual Entity]

Phrase: "critical for initiation of aggregation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511545:Critical [Qualitative Concept]
Processing 00000000.tx.167: Furthermore, once citrate synthase aggregates were formed, PA700 could not disassemble and solubilize them (data not shown). 

Phrase: "Furthermore,"

Phrase: "once"

Phrase: "citrate synthase aggregates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205418:aggregates [Qualitative Concept]
   734   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1413745:citrate synthase [Gene or Genome]

Phrase: "were"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: ","

Phrase: "PA700"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "disassemble"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707798:Disassemble [Activity]

Phrase: "and"

Phrase: "solubilize"

Phrase: "them"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.168: Likewise, PA700 promoted the reactivation of citrate synthase when present at the start of reactivation, but not when added 2min later. 

Phrase: "Likewise,"

Phrase: "PA700"

Phrase: "promoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "the reactivation of citrate synthase"

Phrase: "when"

Phrase: "present at the start of reactivation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "when"

Phrase: "added 2min later."
Processing 00000000.tx.169: In sum, these results suggest that PA700 acts on a non-native conformation not yet fully committed to off-pathway aggregation. 

Phrase: "In sum,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515051:Sum [Quantitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that PA700"

Phrase: "acts on a non-native conformation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0026377:Conformation [Spatial Concept]
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C0302891:Native [Functional Concept]
   753   C1518422:Non [Functional Concept]

Phrase: "not yet fully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Not [Functional Concept]

Phrase: "committed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1171947:committed [Organic Chemical,Pharmacologic Substance]
   966 E C2347840:Commit [Machine Activity]

Phrase: "to off-pathway aggregation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]
   770   C1704259:Pathway [Molecular Function]
   770   C1705987:Pathway [Conceptual Entity]
   770   C1883351:To [Qualitative Concept]
Processing 00000000.tx.170: View larger version (17K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.171: 6.  

Phrase: "6."
Processing 00000000.tx.172: PA700 acts on a partially folded subpopulation. 

Phrase: "PA700"

Phrase: "acts on a partially folded subpopulation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C0332462:Folded [Spatial Concept]
   753   C1257890:Subpopulation [Population Group]
   753   C1880834:FOLDED [Phenomenon or Process]
Processing 00000000.tx.173: A, citrate synthase (150nM) misfolding was initiated as in Fig. 

Phrase: "A,"

Phrase: "citrate synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413745:citrate synthase [Gene or Genome]
   861   C0008857:Citrate [Organic Chemical]
   861   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "(150nM"

Phrase: ")"

Phrase: "misfolding"

Phrase: "was"

Phrase: "initiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.174: 3 in the presence of 7.5nM PA700 (0s) or with 7.5nM PA700 added after the initiation of aggregation (20,60,or 120s). 

Phrase: "3 in the presence of 7.5nM PA700"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0439086:<3 [Quantitative Concept]
   744   C2827736:3+ [Quantitative Concept]
   744   C2981702:3+ [Classification]

Phrase: "(0s"

Phrase: ")"

Phrase: "or with 7.5nM PA700"

Phrase: "added after the initiation of aggregation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]
   753   C0589507:Initiation [Mental Process]
   753   C1158830:Initiation [Genetic Function]
   753   C1524062:Added [Functional Concept]
   753   C1704686:Initiation [Functional Concept]
   719 E C1883712:Add [Functional Concept]

Phrase: "(20,"

Phrase: "60,"

Phrase: "or"

Phrase: "120s"

Phrase: ")."
Processing 00000000.tx.175: B, the reactivation of citrate synthase was assayed and reported as in Fig. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the reactivation of citrate synthase"

Phrase: "was"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.176: 4 with either citrate synthase alone, citrate synthase with PA700 present at the beginning of reactivation, or citrate synthase with PA700 added 2min after the start of reactivation. 

Phrase: "4 with either citrate synthase alone, citrate synthase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1413745:citrate synthase [Gene or Genome]
   744   C0008857:Citrate [Organic Chemical]
   744   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205171:Alone [Quantitative Concept]
   744   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   744   C0439044:alone [Finding]
   744   C0679994:alone [Group Attribute]

Phrase: "with PA700 present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]

Phrase: "at the beginning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Beginning [Temporal Concept]

Phrase: "of reactivation,"

Phrase: "or"

Phrase: "citrate synthase with PA700"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1413745:citrate synthase [Gene or Genome]
   770   C0008857:Citrate [Organic Chemical]
   770   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "2min after the start of reactivation."
Processing 00000000.tx.177: The Base Subcomplex of PA700, Containing ATPase Subunits, Inhibits Aggregation of Misfolded Proteins-- PA700 is composed of 20distinct subunits, including six AAA-ATPases (16, 21, 47, 48), at least one subunit that binds ubiquitin chains (10-12), and an isopeptidase (49). 

Phrase: "The Base Subcomplex of PA700,"

Phrase: "Containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "ATPase Subunits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "Inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Aggregation of Misfolded Proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "--"

Phrase: "PA700"

Phrase: "is"

Phrase: "composed of 20distinct subunits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1711351:Subunit [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "six AAA-ATPases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0001473:ATPases [Amino Acid, Peptide, or Protein,Enzyme]
   793 E C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(16,"

Phrase: "21,"

Phrase: "47,"

Phrase: "48"

Phrase: ")"

Phrase: ","

Phrase: "at least one subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "that"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "ubiquitin chains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:chains [Manufactured Object]
   861   C1524075:Chains [Idea or Concept]

Phrase: "(10-12"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "an isopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064033:isopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.178: The functions of the remaining subunits are unknown. 

Phrase: "The functions of the remaining subunits"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0542341:Functions [Functional Concept]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]

Phrase: "are"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.179: To determine which PA700 subunits are responsible for the effects on inhibition of protein aggregation we repeated some of the experiments described above using subcomplexes of PA700 essentially equivalent to the base and lid complexes described for yeast PA700 (24). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "which PA700 subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "are"

Phrase: "responsible for the effects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "on inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of protein aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]

Phrase: "we"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "some of the experiments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205392:Some [Quantitative Concept]
   770   C0681814:Experiments [Research Activity]
   770   C3540770:Some [Intellectual Product]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "described above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "subcomplexes of PA700"

Phrase: "essentially equivalent to the base"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205163:Equivalent [Qualitative Concept]
   760   C0439185:equivalent [Quantitative Concept]

Phrase: "and"

Phrase: "lid complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "described for yeast PA700"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0036025:yeast [Fungus]
   770   C0043392:Yeast [Food]
   770   C0043393:Yeast [Fungus]
   770   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   770   C1552738:described [Idea or Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.180: The bovine base (in a complex with the 20S proteasome) inhibited aggregation as effectively, if not more effectively, as intact PA700 when compared on a molar basis (Fig. 7A). 

Phrase: "The bovine base"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C1880279:Base [Biomedical or Dental Material]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]

Phrase: "("

Phrase: "in a complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "with the 20S proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
  1000   C1166808:20S proteasome [Cell Component]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: ")"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "as"

Phrase: "effectively,"

Phrase: "if"

Phrase: "not more effectively,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Not [Functional Concept]

Phrase: "as"

Phrase: "intact PA700"

Phrase: "when"

Phrase: "compared on a molar basis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0026367:Molar [Body Part, Organ, or Organ Component]
   760   C1527178:Basis [Functional Concept]
   760   C1707455:Compared [Activity]
   760   C1874451:Basis [Pharmacologic Substance]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.181: The base contains all the ATPases of PA700 and two other subunits (data not shown). 

Phrase: "The base"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002055:base [Inorganic Chemical]
  1000   C0178499:Base [Chemical Viewed Functionally]
  1000   C1880279:Base [Biomedical or Dental Material]
   928 E C0205112:Basal [Spatial Concept]
   916 E C0016617:Foundation [Organization]
   916 E C1626935:Bases [Quantitative Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "all the ATPases of PA700"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0001473:ATPases [Amino Acid, Peptide, or Protein,Enzyme]
   726 E C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1711351:Subunit [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.182: In contrast, lid, which contains the polyubiquitin chain binding subunit, inhibited aggregation of insulin very poorly (Fig. 7B). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "lid,"

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the polyubiquitin chain binding subunit,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C1621498:polyubiquitin binding [Molecular Function]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1711351:Subunit [Quantitative Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "aggregation of insulin very poorly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.183: Similar effects of base and lid were observed with inhibition of citrate synthase aggregation (data not shown). 

Phrase: "Similar effects of base"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "lid"

Phrase: "were"

Phrase: "observed with inhibition of citrate synthase aggregation"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1413745:citrate synthase [Gene or Genome]
   748   C0008857:Citrate [Organic Chemical]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0332621:Aggregation [Functional Concept]
   748   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   748   C0439168:% aggregation [Quantitative Concept]
   748   C1441672:Observed [Functional Concept]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.184: These results suggest that the various functions of PA700 described here are localized to the base component of PA700. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the various functions of PA700"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0542341:Functions [Functional Concept]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here"

Phrase: "are"

Phrase: "localized to the base component of PA700."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0002055:base [Inorganic Chemical]
   748   C0178499:Base [Chemical Viewed Functionally]
   748   C0392752:Localized [Spatial Concept]
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]
   748   C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.185: View larger version (16K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.186: 7.  

Phrase: "7."
Processing 00000000.tx.187: The base subcomplex of PA700, but not the lid subcomplex, inhibits aggregation. 

Phrase: "The base subcomplex of PA700,"

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the lid subcomplex,"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.188: The reductive aggregation of insulin (160M) was performed as in Fig. 

Phrase: "The reductive aggregation of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "(160M"

Phrase: ")"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.189: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.190: A, effect of base on insulin aggregation. 

Phrase: "A,"

Phrase: "effect of base"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on insulin aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.191: Insulin aggregation was initiated in the absence of other proteins (upper line), with 300nM base-proteasome complex (+"base"), and with 300nM PA700 (+PA700). 

Phrase: "Insulin aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]

Phrase: "was"

Phrase: "initiated in the absence of other proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   714   C1548602:Initiate [Idea or Concept]
   714   C1704686:Initiate [Functional Concept]

Phrase: "(upper line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "with 300nM base-proteasome complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(+""base"""
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002055:base [Inorganic Chemical]
  1000   C0178499:Base [Chemical Viewed Functionally]
  1000   C1880279:Base [Biomedical or Dental Material]
   928 E C0205112:Basal [Spatial Concept]
   916 E C0016617:Foundation [Organization]
   916 E C1626935:Bases [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and with 300nM PA700"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "(+PA700"

Phrase: ")."
Processing 00000000.tx.192: B, effect of lid on insulin aggregation. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "effect of lid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on insulin aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.193: Insulin aggregation was initiated in the absence of any other proteins (upper line) and in the presence of either 200nM lid (+"lid") or 130nM PA700 (+PA700).  

Phrase: "Insulin aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]

Phrase: "was"

Phrase: "initiated in the absence of any"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]
   719   C1548602:Initiate [Idea or Concept]
   719   C1704686:Initiate [Functional Concept]

Phrase: "other proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(upper line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "and in the presence of either 200nM lid (+""lid"")"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C1515981:And [Idea or Concept]

Phrase: "or"

Phrase: "130nM PA700"

Phrase: "(+PA700"

Phrase: ")."
Processing 00000000.tx.194: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES This work demonstrates that PA700, the regulatory complex of the 26S proteasome, recognizes non-native conformations of proteins. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "demonstrates"

Phrase: "that PA700,"

Phrase: "the regulatory complex of the 26S proteasome,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "recognizes"

Phrase: "non-native conformations of proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0033625:Protein Conformations [Spatial Concept]
   726   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.195: PA700 inhibited the aggregation of three misfolding proteins and promoted the refolding of a denatured protein to the native state. 

Phrase: "PA700"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the aggregation of three misfolding proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]

Phrase: "and"

Phrase: "promoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "the refolding of a denatured protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C1158944:Protein Refolding [Molecular Function]

Phrase: "to the native state."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0302891:Native [Functional Concept]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]
Processing 00000000.tx.196: These newly discovered functions of PA700 are defining features of molecular chaperones (50-53) and, in combination with the previously established function of PA700 in regulating the degradation of ubiquitinated proteins, place PA700 in a unique and central position for determining the fate of protein substrates as part of the quality control machinery of the cell. 

Phrase: "These newly discovered functions of PA700"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0542341:Functions [Functional Concept]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]

Phrase: "are"

Phrase: "defining features of molecular chaperones"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C1521970:Feature [Qualitative Concept]
   726   C1706388:Feature [Conceptual Entity]
   726   C2346469:Feature [Qualitative Concept]
   726   C2348519:Feature [Qualitative Concept]

Phrase: "(50-53"

Phrase: ")"

Phrase: "and"

Phrase: ","

Phrase: "in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "with the previously established function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "of PA700"

Phrase: "in"

Phrase: "regulating"

Phrase: "the degradation of ubiquitinated proteins,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1519750:Ubiquitinated Protein Degradation [Molecular Function]
   781   C0597297:Protein Degradation [Molecular Function]
   781   C0597304:Protein Degradation [Molecular Function]
   781   C1623036:Protein Degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "place PA700 in a unique"

Phrase: "and"

Phrase: "central position for determining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0733755:Position [Spatial Concept]

Phrase: "the fate of protein substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1539479:FATE [Gene or Genome]

Phrase: "as part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "of the quality control machinery"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0337076:machinery [Manufactured Object]
   734   C0034378:quality control [Functional Concept]
   734   C1561524:Quality Control [Intellectual Product]
   734   C1610034:Quality Control [Intellectual Product]

Phrase: "of the cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.197: Like known chaperones, PA700 could bind to non-native proteins, thereby inhibiting their aggregation and permitting refolding subsequent to their release (Fig. 8). 

Phrase: "Like known chaperones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "PA700"

Phrase: "could"

Phrase: "bind to non-native proteins,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0302891:Native [Functional Concept]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1518422:Non [Functional Concept]

Phrase: "thereby"

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "their aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "permitting refolding subsequent to their release"

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.198: Alternatively, by inhibiting the competing aggregation reaction, PA700 could promote entry of non-native proteins into the degradation pathway, as has been reported for a known molecular chaperone (54). 

Phrase: "Alternatively,"

Phrase: "by inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "the competing aggregation reaction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "PA700"

Phrase: "could"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "entry of non-native proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705654:Entry [Intellectual Product]

Phrase: "into the degradation pathway,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1511758:Degradation Pathway [Conceptual Entity]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "reported for a known molecular chaperone"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0243041:Molecular Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Chaperone
   753   C0205309:Known [Qualitative Concept]
   753   C0684224:Reported [Intellectual Product]
   753   C0700287:Reported [Health Care Activity]
   753   C1521991:Molecular [Qualitative Concept]
   753   C3496591:Reported [Clinical Attribute]
   719 E C3273238:Report [Intellectual Product]

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.199: The possible role of PA700 as a molecular chaperone in the cell may be analogous to known chaperone functions played by ClpA and ClpX, the regulatory subcomplexes of prokaryotic ATP-regulated proteases (55). 

Phrase: "The possible role of PA700"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "as a molecular chaperone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243041:Molecular Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Chaperone

Phrase: "in the cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "analogous to known chaperone functions"

Phrase: "played by ClpA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0600138:played [Finding]
   756 E C0032214:Play [Daily or Recreational Activity]

Phrase: "and"

Phrase: "ClpX,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413508:CLPX [Gene or Genome]

Phrase: "the regulatory subcomplexes of prokaryotic ATP-regulated proteases"

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.200: In addition, PA700 recently has been shown to play a nonproteolytic role in nucleotide excision repair in yeast, perhaps by exerting a chaperone-like activity that disassembles or structurally rearranges the repair complex (56). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "PA700 recently"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a nonproteolytic role in nucleotide excision repair"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in yeast,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036025:yeast [Fungus]
  1000   C0043392:Yeast [Food]
  1000   C0043393:Yeast [Fungus]
  1000   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "perhaps by exerting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015264:exerting [Organism Function]

Phrase: "a chaperone-like activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1149552:chaperone activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "disassembles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707798:Disassemble [Activity]

Phrase: "or"

Phrase: "structurally"

Phrase: "rearranges"

Phrase: "the repair complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(56"

Phrase: ")."
Processing 00000000.tx.201: View larger version (30K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.202: 8.  

Phrase: "8."
Processing 00000000.tx.203: Model for the interactions of the 26S proteasome with protein substrates. 

Phrase: "Model for the interactions of the 26S proteasome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3161035:Model [Intellectual Product]

Phrase: "with protein substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.204: Established (black lines) and hypothetical (gray lines) actions of the 26S proteasome with protein substrates are depicted. 

Phrase: "Established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "(black lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "hypothetical"

Phrase: "(gray lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C1184171:Grey line [Body Location or Region]
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "actions of the 26S proteasome"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441472:actions [Functional Concept]
   726 E C3266814:Action [Activity]

Phrase: "with protein substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "are"

Phrase: "depicted."
Processing 00000000.tx.205: Pathways denoted with heavy arrows represent reactions directly related to the studies in the current report. 

Phrase: "Pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "denoted with heavy arrows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0336721:arrows [Manufactured Object]
   770   C0439539:Heavy [Qualitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "reactions directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "related to the studies"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0163712:Relate [Organic Chemical]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "in the current report."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]
Processing 00000000.tx.206: The model distinguishes four different levels through which proteins are processed. 

Phrase: "The model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "distinguishes"

Phrase: "four different levels through which proteins"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0441889:Levels [Qualitative Concept]
   750   C0428479:Protein level [Laboratory or Test Result]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "processed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]
Processing 00000000.tx.207: At the first level, protein structure is converted between native and non-native forms, either of which may be modified further by ubiquitination. 

Phrase: "At the first level,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "protein structure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175168:protein structure [Amino Acid, Peptide, or Protein]
  1000   C1510464:Protein Structure [Amino Acid, Peptide, or Protein]
   861   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "converted between native"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0302891:Native [Functional Concept]

Phrase: "and"

Phrase: "non-native forms,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0348078:forms [Qualitative Concept]
   827   C0376315:Forms [Manufactured Object]
   793 E C1522492:Form [Functional Concept]

Phrase: "either of which"

Phrase: "may"

Phrase: "be"

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "further by ubiquitination."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1517331:Further [Spatial Concept]
   790   C1519751:Ubiquitination [Molecular Function]
   756 E C0205108:far [Spatial Concept]
Processing 00000000.tx.208: At the second level, the PA700 subcomplex of the 26S proteasome can recognize and interact with each of the protein forms except native nonubiquitinated proteins, for which it has very low affinity. 

Phrase: "At the second level,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "the PA700 subcomplex of the 26S proteasome"

Phrase: "can"

Phrase: "recognize"

Phrase: "and"

Phrase: "interact with each of the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "forms except native nonubiquitinated proteins,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0302891:Native [Functional Concept]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "for which"

Phrase: "it"

Phrase: "has"

Phrase: "very low affinity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0442811:Very low [Finding]
   827   C0205251:low [Qualitative Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1510827:Affinity [Natural Phenomenon or Process]
   827   C1550472:low [Idea or Concept]
Processing 00000000.tx.209: Otherwise, it can bind to the polyububiquitin chain on either the native or non-native protein or with lower affinity to the non-native, nonubiquitinated protein via a second site that recognizes features of non-native structure, as described in the text. 

Phrase: "Otherwise,"

Phrase: "it"

Phrase: "can"

Phrase: "bind to the polyububiquitin chain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0337112:Chain [Manufactured Object]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1524075:Chain [Idea or Concept]

Phrase: "on either"

Phrase: "the native"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0302891:Native [Functional Concept]

Phrase: "or"

Phrase: "non-native protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or with lower affinity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441994:Lower [Spatial Concept]
   770   C1510827:Affinity [Natural Phenomenon or Process]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "to the non-native, nonubiquitinated protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "via a second site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "that"

Phrase: "recognizes"

Phrase: "features of non-native structure,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C1521970:Feature [Qualitative Concept]
   726   C1706388:Feature [Conceptual Entity]
   726   C2346469:Feature [Qualitative Concept]
   726   C2348519:Feature [Qualitative Concept]

Phrase: "as"

Phrase: "described in the text."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1527021:Text [Intellectual Product]
   770   C1552738:described [Idea or Concept]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]
Processing 00000000.tx.210: Assuming the two sites are energetically coupled, the non-native ubiquitinated substrate would be the most likely to bind the PA700 subcomplex. 

Phrase: "Assuming"

Phrase: "the two sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "energetically"

Phrase: "coupled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupled [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: ","

Phrase: "the non-native ubiquitinated substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1710236:Substrate [Manufactured Object]

Phrase: "would"

Phrase: "be"

Phrase: "the most likely to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0750501:most likely [Idea or Concept]
   827   C0205393:Most [Quantitative Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]
   755 E C0033204:Likelihood [Quantitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the PA700 subcomplex."
Processing 00000000.tx.211: At the third level, the substrate protein is edited by one or more of the activities of the PA700 subcomplex. 

Phrase: "At the third level,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "the substrate protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "edited by one"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205447:One [Quantitative Concept]
   756   C0868955:Edit [Occupational Activity]

Phrase: "or"

Phrase: "more of the activities of the PA700 subcomplex."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   744   C0205172:More [Functional Concept]
   744   C0441655:Activities [Activity]
   711 E C0205177:Activity [Functional Concept]
   711 E C0439167:% activity [Quantitative Concept]
   711 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.212: The relative outcome of these activities is determined at the fourth level, substrate fate, and includes: recovery of the native substrate as a consequence of isopeptidase activity, degradation as a consequence of the action of ATP-dependent protease activity, or as described in this text, refolding of the non-native structure to a native structure. 

Phrase: "The relative outcome of these activities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1274040:Outcome [Functional Concept]

Phrase: "is"

Phrase: "determined at the fourth level,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205438:Fourth [Quantitative Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C1706303:Fourth [Qualitative Concept]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "substrate fate,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1539479:FATE [Gene or Genome]
   789 E C1302234:Fatal [Qualitative Concept]
   789 E C1705232:Fatal [Finding]

Phrase: "and"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: ":"

Phrase: "recovery of the native substrate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0237820:Recovery [Activity]
   760   C1555688:recovery [Idea or Concept]
   760   C2004454:Recovery [Organism Function]

Phrase: "as a consequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "of isopeptidase activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2610774:isopeptidase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "degradation as a consequence of the action of ATP-dependent protease activity,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   751   C1510699:ATP degradation [Molecular Function]
   736   C0243125:degradation [Functional Concept]
   736   C0699900:Degradation [Organism Function]

Phrase: "or"

Phrase: "as"

Phrase: "described in this text,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1527021:Text [Intellectual Product]
   770   C1552738:described [Idea or Concept]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]

Phrase: "refolding of the non-native structure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0302891:Native [Functional Concept]
   753   C0678594:Structure [Spatial Concept]
   753   C1518422:Non [Functional Concept]

Phrase: "to a native structure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.213: The model also depicts the formation of aggregates, which is the fate of non-native structures that escape recognition and editing by the 26S proteasome. 

Phrase: "The model also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "depicts"

Phrase: "the formation of aggregates,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "the fate of non-native structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1539479:FATE [Gene or Genome]

Phrase: "that escape recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0524637:Recognition [Mental Process]

Phrase: "and"

Phrase: "editing by the 26S proteasome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0868955:Editing [Occupational Activity]
Processing 00000000.tx.214: Several features of the effects of PA700 reported here are atypical of many well characterized molecular chaperones and provide insights regarding their possible physiological significance. 

Phrase: "Several features of the effects of PA700"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   714   C1521970:Feature [Qualitative Concept]
   714   C1706388:Feature [Conceptual Entity]
   714   C2346469:Feature [Qualitative Concept]
   714   C2348519:Feature [Qualitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "are"

Phrase: "atypical of many well characterized molecular chaperones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205182:Atypical [Qualitative Concept]
   748   C0741302:Atypical [Finding]

Phrase: "and"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "insights"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233820:insights [Mental Process]

Phrase: "regarding"

Phrase: "their possible physiological significance."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0237881:Significance [Quantitative Concept]
   827   C0750502:Significance [Idea or Concept]
   755 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.215: PA700 inhibited the aggregation of misfolded proteins at very low PA700:protein substrate ratios, whereas other chaperones normally require near stoichiometric ratios for function. 

Phrase: "PA700"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the aggregation of misfolded proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]

Phrase: "at very low PA700"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0442811:Very low [Finding]

Phrase: ":"

Phrase: "protein substrate ratios,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0456603:Ratios [Quantitative Concept]
   827   C1610540:*Ratios [Quantitative Concept]
   793 E C1547037:Ratio [Intellectual Product]

Phrase: "whereas"

Phrase: "other chaperones normally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "require near stoichiometric ratios"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0456603:Ratios [Quantitative Concept]
   770   C1610540:*Ratios [Quantitative Concept]
   737 E C1547037:Ratio [Intellectual Product]

Phrase: "for function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.216: For example, 30-100 times more Hsc70 was required to achieve the same degree of inhibition accomplished by PA700 in the assays reported here (data not shown and Ref. 26). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "30-100 times more Hsc70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1415764:HSC70 [Gene or Genome]

Phrase: "was"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "achieve"

Phrase: "the same degree of inhibition"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "accomplished by PA700"

Phrase: "in the assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "Ref. 26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.217: These results indicate that PA700 interacts with a subpopulation of proteins in a conformation prone to aggregation. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that PA700"

Phrase: "interacts with a subpopulation of proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1257890:Subpopulation [Population Group]

Phrase: "in a conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026377:Conformation [Spatial Concept]

Phrase: "prone to aggregation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033422:Prone [Spatial Concept]
Processing 00000000.tx.218: Thus, to inhibit aggregation effectively, PA700 need not bind each substrate molecule, but only those disposed to off-pathway associations. 

Phrase: "Thus,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "aggregation effectively,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]

Phrase: "PA700"

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "each substrate molecule,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "but"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "those"

Phrase: "disposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707797:Dispose [Activity]

Phrase: "to off-pathway associations."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0004083:Associations [Mental Process]
   770   C1704259:Pathway [Molecular Function]
   770   C1705987:Pathway [Conceptual Entity]
   770   C1883351:To [Qualitative Concept]
   737 E C0439849:Association [Qualitative Concept]
   737 E C0596306:Association [Phenomenon or Process]
   737 E C0699792:association [Social Behavior]
Processing 00000000.tx.219: Additionally, order-of-addition experiments suggest that PA700 likely recognizes a conformation early in the misfolding process. 

Phrase: "Additionally,"

Phrase: "order-of-addition experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that PA700 likely"

Phrase: "recognizes"

Phrase: "a conformation early in the misfolding process."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.220: These features are consistent with the observation that PA700 lengthens the lag phase for aggregation of both insulin (Fig. 2C) and citrate synthase (Fig. 3) in a concentration-dependent manner. 

Phrase: "These features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1521970:Feature [Qualitative Concept]
   966   C1706388:Feature [Conceptual Entity]
   966   C2346469:Feature [Qualitative Concept]
   966   C2348519:Feature [Qualitative Concept]

Phrase: "are"

Phrase: "consistent with the observation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that PA700"

Phrase: "lengthens"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392744:lengthen [Functional Concept]
  1000   C0441592:lengthen [Therapeutic or Preventive Procedure]

Phrase: "the lag phase for aggregation of both insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205390:Phase [Temporal Concept]
   744   C1416797:Lag [Gene or Genome]

Phrase: "(Fig. 2C"

Phrase: ")"

Phrase: "and"

Phrase: "citrate synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413745:citrate synthase [Gene or Genome]
   861   C0008857:Citrate [Organic Chemical]
   861   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "in a concentration-dependent manner."
Processing 00000000.tx.221: The lag phase observed in each of these aggregation processes is likely due to the formation of a specific conformation or nucleus prone to self-association that PA700 may recognize and interact with. 

Phrase: "The lag phase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205390:Phase [Temporal Concept]
   861   C1416797:Lag [Gene or Genome]

Phrase: "observed in each of these aggregation processes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0332621:Aggregation [Functional Concept]
   748   C0439168:% aggregation [Quantitative Concept]
   748   C1441672:Observed [Functional Concept]
   714   C1184743:Process [Body Part, Organ, or Organ Component]
   714   C1522240:Process [Phenomenon or Process]

Phrase: "is"

Phrase: "likely due to the formation of a specific conformation"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0678226:Due to [Functional Concept]
           due
   742   C0026377:Conformation [Spatial Concept]
   742   C0205369:Specific [Qualitative Concept]
   742   C0220781:formation [Biologic Function]
   742   C0332148:Likely [Qualitative Concept]
   742   C0439634:formation [Spatial Concept]
   742   C0750492:Likely [Idea or Concept]
   742   C1522492:Formation [Functional Concept]
   742   C1552740:specific [Intellectual Product]
   742   C3146286:Due [Idea or Concept]

Phrase: "or"

Phrase: "nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "prone to self-association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033422:Prone [Spatial Concept]

Phrase: "that PA700"

Phrase: "may"

Phrase: "recognize"

Phrase: "and"

Phrase: "interact with."
Processing 00000000.tx.222: Finally, PA700 does not require ATP either to inhibit aggregation or to promote refolding. 

Phrase: "Finally,"

Phrase: "PA700"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "ATP either to"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "or"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "refolding."
Processing 00000000.tx.223: Many previously characterized molecular chaperones utilize ATP hydrolysis as a timing mechanism to coordinate the rate of substrate binding and release with the rate of substrate folding, rather than utilizing the hydrolytic energy to promote an otherwise unfavorable reaction. 

Phrase: "Many previously"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "molecular chaperones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243041:Molecular Chaperones [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Chaperone

Phrase: "utilize"

Phrase: "ATP hydrolysis as a timing mechanism to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1510699:ATP Hydrolysis [Molecular Function]
   748   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "coordinate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0427184:coordinate [Finding]
  1000   C0700114:coordinate [Functional Concept]
  1000   C1707511:Coordinate [Spatial Concept]

Phrase: "the rate of substrate binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "release with the rate of substrate folding,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "rather than"

Phrase: "utilizing"

Phrase: "the hydrolytic energy to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0424589:Energy [Finding]
   827   C0542479:Energy [Natural Phenomenon or Process]
   827   C1442080:Energy [Quantitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "an otherwise unfavorable reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.224: Therefore, the current results may indicate that the known ATP requirement for protein degradation by the 26S proteasome supports energy-dependent unfolding or processive translocation of unfolded substrates to the proteasome active sites by PA700. 

Phrase: "Therefore,"

Phrase: "the current results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "may"

Phrase: "indicate"

Phrase: "that"

Phrase: "the known ATP requirement for protein degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0556043:Protein requirement [Finding]
   748   C1514873:Requirement [Functional Concept]

Phrase: "by the 26S proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "energy-dependent unfolding"

Phrase: "or"

Phrase: "processive translocation of unfolded substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040715:Translocation [Cell or Molecular Dysfunction]
   760   C2987521:Translocation [Activity]

Phrase: "to the proteasome active sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0205681:Sites, Active [Functional Concept]
   827   C0205145:Sites [Spatial Concept]
   827   C0205177:Active [Functional Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "by PA700."
Processing 00000000.tx.225: While this manuscript was in preparation, Braun et al. 

Phrase: "While"

Phrase: "this manuscript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]

Phrase: "was in preparation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0455052:Preparation [Health Care Activity]
   790   C1421478:WAS [Gene or Genome]
   790   C1521827:Preparation [Functional Concept]

Phrase: "Braun et al."
Processing 00000000.tx.226: (57) reported that the 26S proteasome inhibited the aggregation and promoted the refolding of citrate synthase, one of the substrates used in the current study. 

Phrase: "(57"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the 26S proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "promoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "the refolding of citrate synthase,"

Phrase: "one of the substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "used in the current study."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   781   C0869040:study use [Research Activity]
   760   C0521116:Current [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1273517:used [Finding]
   760   C1705970:Current [Natural Phenomenon or Process]
   760   C2603343:Study [Research Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.227: Both of these activities were localized to the base of PA700. 

Phrase: "Both of these activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0238767:Both [Spatial Concept]
   770   C0441655:Activities [Activity]
   770   C1706086:Both [Qualitative Concept]
   737 E C0205177:Activity [Functional Concept]
   737 E C0439167:% activity [Quantitative Concept]
   737 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "localized to the base of PA700."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0002055:base [Inorganic Chemical]
   753   C0178499:Base [Chemical Viewed Functionally]
   753   C0392752:Localized [Spatial Concept]
   753   C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.228: Although the results of the two studies are in general agreement, they differ in several important ways. 

Phrase: "Although"

Phrase: "the results of the two studies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0683954:results studies [Finding]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "are in general agreement,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205246:General [Spatial Concept]
   770   C0680240:Agreement [Social Behavior]
   770   C1551058:Are [Quantitative Concept]
   770   C1553889:General [Idea or Concept]

Phrase: "they"

Phrase: "differ in several important ways."
Processing 00000000.tx.229: First, much higher protein:substrate ratios were required for the effects reported by Braun et al. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "much higher protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "substrate ratios"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0456603:Ratios [Quantitative Concept]
   861   C1610540:*Ratios [Quantitative Concept]
   827 E C1547037:Ratio [Intellectual Product]

Phrase: "were"

Phrase: "required for the effects"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1280500:effects [Qualitative Concept]
   770   C1514873:Required [Functional Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "reported by Braun et al."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1709908:Reported By [Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.230: (57) than for those needed here. 

Phrase: "(57"

Phrase: ")"

Phrase: "than"

Phrase: "for those needed here."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027552:Needed [Qualitative Concept]
   861   C0686904:needed [Functional Concept]
Processing 00000000.tx.231: Second, ATP promoted a small stimulation of inhibition in their experiments. 

Phrase: "Second, ATP"

Phrase: "promoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "a small stimulation of inhibition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in their experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.232: Third, consistent with the low stoichiometry or possibly the dynamic nature of the complex, we were unable to detect significant amounts of association of either insulin or citrate synthase with PA700 during density gradient centrifugation (data not shown). 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "consistent with the low stoichiometry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "or"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "the dynamic nature of the complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0349590:Nature [Idea or Concept]
   753   C1262865:Nature [Functional Concept]

Phrase: "we"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "significant amounts of association of either insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:amounts [Quantitative Concept]

Phrase: "or"

Phrase: "citrate synthase with PA700"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1413745:citrate synthase [Gene or Genome]
   770   C0008857:Citrate [Organic Chemical]
   770   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "during density gradient centrifugation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0007704:Centrifugation, Density Gradient [Laboratory Procedure]
   827   C0007703:Centrifugation [Laboratory Procedure]
   827   C0178587:density [Quantitative Concept]
   827   C0439182:% gradient [Quantitative Concept]
   827   C0812409:Gradient [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.233: The basis for these differences is unclear but may have significant consequences for interpretation of the mechanisms in which these processes are involved (see below). 

Phrase: "The basis for these differences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1527178:Basis [Functional Concept]
   760   C1874451:Basis [Pharmacologic Substance]

Phrase: "is"

Phrase: "unclear"

Phrase: "but"

Phrase: "may"

Phrase: "have"

Phrase: "significant consequences for interpretation of the mechanisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "in which"

Phrase: "these processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "are"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.234: What are the physiological implications of the current results? 

Phrase: "What"

Phrase: "are"

Phrase: "the physiological implications of the current results?"
Processing 00000000.tx.235: Regardless of whether PA700, either alone or as part of the 26S proteasome, functions independently as a molecular chaperone in the cell, the novel activities described here are directly relevant to its established function in the degradation of ubiquitinated proteins. 

Phrase: "Regardless of"

Phrase: "whether"

Phrase: "PA700,"

Phrase: "either alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "or as part of the 26S proteasome,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1166804:26S proteasome [Cell Component]
   778   C1292711:Part of [Spatial Concept]
   748   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0449719:Part [Spatial Concept]
   748   C1325620:proteasome [Cell Component]
   748   C1552140:26s [Body Part, Organ, or Organ Component]
   748   C1709471:Part [Quantitative Concept]
   748   C1752727:Proteasome [Molecular Function]

Phrase: "functions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "independently as a molecular chaperone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0243041:Molecular Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Chaperone
   760   C1521991:Molecular [Qualitative Concept]

Phrase: "in the cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "the novel activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here"

Phrase: "are"

Phrase: "directly relevant to its established function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347946:Relevant [Qualitative Concept]

Phrase: "in the degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "of ubiquitinated proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1956096:Ubiquitinated Proteins [Amino Acid, Peptide, or Protein]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.236: For example, PA700 must contain a binding site for non-native protein structures as an essential feature for its role in proteolysis because non-native structures are the products of unfolding reactions and the substrates for translocation reactions that are part of the putative proteolytic mechanism. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "PA700"

Phrase: "must"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a binding site for non-native protein"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0005456:Binding Site [Receptor]
   778   C0682969:Binding Site [Amino Acid Sequence]
   774   C0033618:Protein Binding [Molecular Function]
   774   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205145:Site [Spatial Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "structures as an essential feature"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205224:Essential [Qualitative Concept]
   760   C0678594:Structure [Spatial Concept]
   760   C1521970:Feature [Qualitative Concept]
   760   C1706388:Feature [Conceptual Entity]
   760   C2346469:Feature [Qualitative Concept]
   760   C2348519:Feature [Qualitative Concept]

Phrase: "for its role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "in proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "because"

Phrase: "non-native structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "are"

Phrase: "the products of unfolding reactions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1514468:Products [Entity]
   726 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "the substrates for translocation reactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1710236:Substrate [Manufactured Object]

Phrase: "that"

Phrase: "are"

Phrase: "part of the putative proteolytic mechanism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.237: The potential function of this site for both protein folding and protein degradation is illustrated in the model proposed in Fig. 

Phrase: "The potential function of this site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "for both protein folding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162847:protein folding [Molecular Function]
   861   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "protein degradation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0597297:Protein Degradation [Molecular Function]
  1000   C0597304:Protein Degradation [Molecular Function]
  1000   C1623036:Protein Degradation [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "illustrated in the model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3161035:Model [Intellectual Product]

Phrase: "proposed in Fig."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1441414:PROPOSED [Idea or Concept]
   790   C1553874:Proposed [Qualitative Concept]
   790   C1578820:Proposed [Idea or Concept]
Processing 00000000.tx.238: 8. 

Phrase: "8."
Processing 00000000.tx.239: In this model, PA700 may bind to: (i) native ubiquitinated proteins (via recognition of polyubiquitin chains), (ii) non-native nonubiquitinated proteins (via recognition of non-native protein structure), or (iii) non-native ubiquitinated proteins (via recognition of both polyubiquitin chains and non-native protein structure). 

Phrase: "In this model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "PA700"

Phrase: "may"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: ":"

Phrase: "(i) native ubiquitinated proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   886   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1956096:Ubiquitinated Proteins [Amino Acid, Peptide, or Protein]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "via recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0524637:Recognition [Mental Process]

Phrase: "of polyubiquitin chains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:chains [Manufactured Object]
   861   C1524075:Chains [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "(ii"

Phrase: ")"

Phrase: "non-native nonubiquitinated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "via recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0524637:Recognition [Mental Process]

Phrase: "of non-native protein structure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175168:protein structure [Amino Acid, Peptide, or Protein]
   861   C1510464:Protein Structure [Amino Acid, Peptide, or Protein]
   812   C0678594:Structure [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "or (iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "non-native ubiquitinated proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1956096:Ubiquitinated Proteins [Amino Acid, Peptide, or Protein]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "via recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0524637:Recognition [Mental Process]

Phrase: "of both polyubiquitin chains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:chains [Manufactured Object]
   861   C1524075:Chains [Idea or Concept]

Phrase: "and"

Phrase: "non-native protein structure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175168:protein structure [Amino Acid, Peptide, or Protein]
   861   C1510464:Protein Structure [Amino Acid, Peptide, or Protein]
   812   C0678594:Structure [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.240: These multiple recognition and binding modes would allow PA700 to serve a central editing function that determines the final fate of substrates. 

Phrase: "These multiple recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0524637:Recognition [Mental Process]

Phrase: "and"

Phrase: "binding modes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1513371:Mode [Functional Concept]
   827   C1705738:Mode [Quantitative Concept]
   827   C2347637:Mode [Quantitative Concept]
   827   C2348146:Mode [Quantitative Concept]

Phrase: "would"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "PA700 to"

Phrase: "serve"

Phrase: "a central editing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0868955:Editing [Occupational Activity]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "that"

Phrase: "determines"

Phrase: "the final fate of substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1539479:FATE [Gene or Genome]
Processing 00000000.tx.241: For example, the known isopeptidase activity of PA700 may promote the removal of polyubiquitin chains from both native and non-native proteins (49). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "the known isopeptidase activity of PA700"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C2610774:isopeptidase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "may"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the removal of polyubiquitin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015252:Removal [Therapeutic or Preventive Procedure]
   770   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "chains from both native"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0302891:Native [Functional Concept]
   770   C0337112:Chain [Manufactured Object]
   770   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "non-native proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.242: Inappropriately ubiquitinated native proteins, thus, could be recovered directly, whereas release of the non-native conformer would be less likely due to interactions with the non-native binding site. 

Phrase: "Inappropriately ubiquitinated native proteins,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1956096:Ubiquitinated Proteins [Amino Acid, Peptide, or Protein]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0302891:Native [Functional Concept]

Phrase: "thus,"

Phrase: "could"

Phrase: "be"

Phrase: "recovered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]

Phrase: "directly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "whereas"

Phrase: "release of the non-native conformer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "would"

Phrase: "be"

Phrase: "less likely due to interactions"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0332148:Likely [Qualitative Concept]
   760   C0439092:less [Intellectual Product]
   760   C0547044:Less [Qualitative Concept]
   760   C0750492:Likely [Idea or Concept]
   760   C3146286:Due [Idea or Concept]
   726   C1704675:Interaction [Functional Concept]

Phrase: "with the non-native binding site."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0005456:Binding Site [Receptor]
   861   C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]
Processing 00000000.tx.243: Alternatively, PA700 may promote the unfolding of bound native or partially folded, ubiquitinated proteins as a prerequisite for their degradation. 

Phrase: "Alternatively,"

Phrase: "PA700"

Phrase: "may"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the unfolding of bound native"

Phrase: "or"

Phrase: "partially"

Phrase: "folded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Folded [Spatial Concept]
  1000   C1880834:FOLDED [Phenomenon or Process]

Phrase: ","

Phrase: "ubiquitinated proteins as a prerequisite"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1956096:Ubiquitinated Proteins [Amino Acid, Peptide, or Protein]
   781   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for their degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]
Processing 00000000.tx.244: This process requires a site for binding the product of the unfolding reaction, and the current data provide strong evidence for the existence of such a site on PA700. 

Phrase: "This process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "requires"

Phrase: "a site for binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0005456:Binding Site [Receptor]
   819   C0682969:Binding Site [Amino Acid Sequence]
   770   C0205145:Site [Spatial Concept]
   770   C1515974:Site [Body Location or Region]
   770   C2825164:Site [Spatial Concept]

Phrase: "the product of the unfolding reaction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1514468:product [Entity]
   753   C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "the current data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "strong evidence for the existence of such"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "a site on PA700."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205145:Site [Spatial Concept]
   770   C1515974:Site [Body Location or Region]
   770   C2825164:Site [Spatial Concept]
Processing 00000000.tx.245: Finally, as discussed above, PA700 may contribute directly to the recognition and disposition of non-native nonubiquitinated proteins. 

Phrase: "Finally,"

Phrase: "as"

Phrase: "discussed above,"

Phrase: "PA700"

Phrase: "may"

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "directly to the recognition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0524637:Recognition [Mental Process]
   770   C1947931:Directly [Qualitative Concept]

Phrase: "and"

Phrase: "disposition of non-native nonubiquitinated proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0743223:Disposition [Idea or Concept]
   753   C1705555:Disposition [Idea or Concept]
Processing 00000000.tx.246: Elucidation of the relative affinities and coupling between the polyubiquitin and non-native protein binding sites and isopeptidase active site of PA700, depicted in the thermodynamic cycle shown in Fig. 

Phrase: "Elucidation of the relative affinities"

Phrase: "and"

Phrase: "coupling between the polyubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1948027:Coupling [Functional Concept]

Phrase: "and"

Phrase: "non-native protein binding sites"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   840   C0005456:Binding Sites [Receptor]
   840   C0033618:Protein Binding [Molecular Function]
   806 E C0682969:Binding Site [Amino Acid Sequence]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0205145:Sites [Spatial Concept]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   771 E C1515974:Site [Body Location or Region]
   771 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "isopeptidase active site of PA700,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0205681:Active Site [Functional Concept]
   806   C2945843:Site of [Qualitative Concept]
   760   C0205145:Site [Spatial Concept]
   760   C0205177:Active [Functional Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "depicted in the thermodynamic cycle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0039808:Thermodynamic [Occupation or Discipline]
   760   C1511572:Cycle [Temporal Concept]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.247: 8, will be required for understanding the molecular details of how the 26S proteasome determines the ultimate fate of protein substrates.  

Phrase: "8,"

Phrase: "will"

Phrase: "be"

Phrase: "required for understanding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0162340:Understanding [Mental Process]
   790   C1514873:Required [Functional Concept]

Phrase: "the molecular details of how"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1522508:Details [Qualitative Concept]
   726 E C1561567:detail [Functional Concept]

Phrase: "the 26S proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1166804:26S proteasome [Cell Component]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1552140:26s [Body Part, Organ, or Organ Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "determines"

Phrase: "the ultimate fate of protein substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1539479:FATE [Gene or Genome]
Processing 00000000.tx.248: ACKNOWLEDGEMENTS We thank Dr. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.249: Chris Wigley and Rhesa Stidham for critical reading of the manuscript, Rajen Desai and Linda Millen for technical assistance, the laboratory of Dr. 

Phrase: "Chris Wigley"

Phrase: "and"

Phrase: "Rhesa Stidham for critical reading of the manuscript,"

Phrase: "Rajen Desai"

Phrase: "and"

Phrase: "Linda Millen for technical assistance,"

Phrase: "the laboratory of Dr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3244292:laboratory [Functional Concept]
Processing 00000000.tx.250: David Chuang for useful suggestions, and the Thomas and DeMartino laboratories for many beneficial conversations.  

Phrase: "David Chuang for useful suggestions,"

Phrase: "and"

Phrase: "the Thomas"

Phrase: "and"

Phrase: "DeMartino laboratories for many beneficial conversations."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0022877:Laboratories [Manufactured Object,Organization]
   753   C1619828:Laboratories [Intellectual Product]
   719 E C3244292:laboratory [Functional Concept]
Processing 00000000.tx.251: FOOTNOTES * This work was supported by NIDDK, National Institutes of Health (NIH) Grant DK49835 (to P.J.T.), the Robert Welch Foundation I-1284 (to P.J.T.), NIDDK, NIH DK46181 (G.N.D.), and the Muscular Dystrophy Association (G.N.D.).

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by NIDDK,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1513898:NIDDK [Health Care Related Organization]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]

Phrase: "National Institutes of Health (NIH) Grant DK49835"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027468:National Institutes of Health [Health Care Related Organization]

Phrase: "("

Phrase: "to P.J."

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "the Robert"

Phrase: "Welch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043114:Welsh [Population Group]

Phrase: "Foundation I-1284"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   827   C0016617:Foundation [Organization]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "("

Phrase: "to P.J."

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "NIDDK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1513898:NIDDK [Health Care Related Organization]

Phrase: "NIH DK46181"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health

Phrase: "(G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "D."

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the Muscular Dystrophy Association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
   734   C0026850:Muscular Dystrophy [Congenital Abnormality,Disease or Syndrome]

Phrase: "(G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "D."

Phrase: ")."
Processing 00000000.tx.252: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.253: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.254: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.255: This work is dedicated to the late Dr. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "is"

Phrase: "dedicated to the late Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031831:DR [Professional or Occupational Group]
   760   C0205087:Late [Temporal Concept]
   760   C1707664:DR [Biomedical or Dental Material]
   760   C2348314:Dr. [Conceptual Entity]
   760   C3540849:DR [Idea or Concept]
Processing 00000000.tx.256: Paul Srere who was kind enough to have many helpful discussions with us.  

Phrase: "Paul Srere"

Phrase: "who"

Phrase: "was"

Phrase: "kind enough to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332307:Kind [Qualitative Concept]

Phrase: "have"

Phrase: "many helpful discussions with us."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0557061:discussions [Therapeutic or Preventive Procedure]
   726 E C2584313:Discussion [Social Behavior]
Processing 00000000.tx.257: Established investigator of the American Heart Association (9740033N). 

Phrase: "Established investigator of the American Heart Association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0035173:Investigator [Professional or Occupational Group]

Phrase: "(9740033N"

Phrase: ")."
Processing 00000000.tx.258: To whom correspondence may be addressed: 5323Harry Hines Blvd., Dallas, TX 75235-9040.

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "5323Harry Hines Blvd.,"

Phrase: "Dallas,"

Phrase: "TX 75235-9040."
Processing 00000000.tx.259: For G.N.D., Tel.: 

Phrase: "For G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.260: 214-648-3308; 

Phrase: "214-648-3308"

Phrase: ";"
Processing 00000000.tx.261: Fax: 214-648-4771; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "214-648-4771"

Phrase: ";"
Processing 00000000.tx.262: E-mail: gdemar@mednet.swmed.edu. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "gdemar@mednet.swmed.edu."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.263: For P.J.T., Tel.: 

Phrase: "For P.J.T.,"

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.264: 214-648-8723; 

Phrase: "214-648-8723"

Phrase: ";"
Processing 00000000.tx.265: Fax: 214-648-9268; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "214-648-9268"

Phrase: ";"
Processing 00000000.tx.266: E-mail: thomas07@utsw.swmed.edu. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "thomas07@utsw.swmed.edu."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.267: 2 K. 

Phrase: "2 K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.268: Hakala and G.N.DeMartino, manuscript in preparation.  

Phrase: "Hakala"

Phrase: "and"

Phrase: "G.N.DeMartino,"

Phrase: "manuscript in preparation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.269: ABBREVIATIONS The abbreviations used are: PA700, proteasome activator, 700kDa; 

Phrase: "ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "PA700,"

Phrase: "proteasome activator,"

Phrase: "700kDa"

Phrase: ";"
Processing 00000000.tx.270: CFTR, cystic fibrosis transmembrane conductance regulator; 

Phrase: "CFTR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0056889:CFTR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413365:CFTR [Gene or Genome]

Phrase: "cystic fibrosis transmembrane conductance regulator"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
  1000   C0056889:Cystic Fibrosis Transmembrane Conductance Regulator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413365:CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR [Gene or Genome]
   840   C0010674:Cystic Fibrosis [Disease or Syndrome]
   804   C0016059:Fibrosis [Pathologic Function]
   804   C0182953:REGULATOR [Medical Device]
   804   C0205207:Cystic [Qualitative Concept]
   804   C1167322:transmembrane [Cell Component]
   804   C1704734:Regulator [Medical Device]
   804   C1704735:Regulator [Conceptual Entity]
   804   C2752508:transmembrane [Cell Component]
   733 E C0010709:Cyst [Disease or Syndrome]
   733 E C0334129:Fibrotic [Functional Concept]
   733 E C0686883:Cyst [Eukaryote]

Phrase: ";"
Processing 00000000.tx.271: NBD1, nucleotide binding domain 1; 

Phrase: "NBD1,"

Phrase: "nucleotide binding domain 1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C1148916:nucleotide binding [Molecular Function]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.272: F-NBD1, F508 mutant N-terminal nucleotide binding domain of CFTR; 

Phrase: "F-NBD1,"

Phrase: "F508 mutant N-terminal nucleotide binding domain of CFTR"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   784   C1323338:N-terminal binding [Molecular Function]
   764   C1148916:nucleotide binding [Molecular Function]
   742   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.273: PA28, proteasome activator, 28kDa; 

Phrase: "PA28,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1166811:PA28 [Cell Component]

Phrase: "proteasome activator,"

Phrase: "28kDa"

Phrase: ";"
Processing 00000000.tx.274: CS, citrate synthase; 

Phrase: "CS,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413745:citrate synthase [Gene or Genome]
   861   C0008857:Citrate [Organic Chemical]
   861   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "citrate synthase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008855:Citrate Synthase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413745:citrate synthase [Gene or Genome]
   861   C0008857:Citrate [Organic Chemical]
   861   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.275: ATPS, adenosine 5'-O-(thiotriphosphate); 

Phrase: "ATPS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004482:atps [Organic Chemical,Pharmacologic Substance]

Phrase: "adenosine 5'-O-(thiotriphosphate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0101539:adenosine 5'-O-thiotriphosphate [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
           adenosine 5'-thiotriphosphate

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.276: GdnHCl, guanidinium hydrochloride; 

Phrase: "GdnHCl,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120447:Guanidine Hydrochloride [Organic Chemical,Pharmacologic Substance]
   861   C0018320:guanidine [Organic Chemical]
   861   C0120446:Guanidine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   861   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "guanidinium hydrochloride"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0120446:Guanidinium [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   861   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.277: NEM, N- ethylmaleimide.  

Phrase: "NEM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015101:N-Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Ethylmaleimide

Phrase: "N- ethylmaleimide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015101:N-Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Ethylmaleimide
Processing 00000000.tx.278: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.279: DeMartino, G. 

Phrase: "DeMartino,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.280: N., and Slaughter, C. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Slaughter,"

Phrase: "C."
Processing 00000000.tx.281: A. 

Phrase: "A."
Processing 00000000.tx.282: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.283: Biol. 

Phrase: "Biol."
Processing 00000000.tx.284: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.285: 274, 22123-22126[Free FullText] 2. 

Phrase: "274,"

Phrase: "22123-22126"

Phrase: "[Free FullText"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.286: Coux, O., Tanaka, K., and Goldberg, A. 

Phrase: "Coux,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Tanaka,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Goldberg,"

Phrase: "A."
Processing 00000000.tx.287: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.288: (1996) Annu. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.289: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.290: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.291: 65, 801-847[CrossRef][Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "801-847"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.292: Baumeister, W., Walz, J., Zuhl, F., and Seemuller, E. 

Phrase: "Baumeister,"

Phrase: "W.,"

Phrase: "Walz,"

Phrase: "J.,"

Phrase: "Zuhl,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Seemuller,"

Phrase: "E."
Processing 00000000.tx.293: (1998) Cell 92, 367-380[Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Cell 92,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "367-380"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.294: Peters, J.-M. 

Phrase: "Peters,"

Phrase: "J.-M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.295: (1994) Trends Biochem. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.296: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.297: 19, 377-382[CrossRef][Medline] [OrderarticleviaInfotrieve] 5. 

Phrase: "19,"

Phrase: "377-382"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.298: Bochtler, M., Ditzel, L., Groll, M., Hartmann, C., and Huber, R. 

Phrase: "Bochtler,"

Phrase: "M."

Phrase: ","

Phrase: "Ditzel,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Groll,"

Phrase: "M."

Phrase: ","

Phrase: "Hartmann,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Huber,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.299: (1999) Annu. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.300: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.301: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.302: Biomol. 

Phrase: "Biomol."
Processing 00000000.tx.303: Struct. 

Phrase: "Struct."
Processing 00000000.tx.304: 28, 295-317[CrossRef][Medline] [OrderarticleviaInfotrieve] 6. 

Phrase: "28,"

Phrase: "295-317"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 6."
Processing 00000000.tx.305: Groll, M., Ditzel, L., Lowe, J., Stock, D., Bochtler, M., Bartunik, H. 

Phrase: "Groll,"

Phrase: "M."

Phrase: ","

Phrase: "Ditzel,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lowe,"

Phrase: "J.,"

Phrase: "Stock,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710198:Stock [Idea or Concept]

Phrase: "D."

Phrase: ","

Phrase: "Bochtler,"

Phrase: "M."

Phrase: ","

Phrase: "Bartunik,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.306: D., and Huber, R. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Huber,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.307: (1997) Nature 386, 463-471[CrossRef][Medline] [OrderarticleviaInfotrieve] 7. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nature 386,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "463-471"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 7."
Processing 00000000.tx.308: Hoffman, L., Pratt, G., Ferrell, K., and Rechsteiner, M. 

Phrase: "Hoffman,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Pratt,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ferrell,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Rechsteiner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.309: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.310: Biol. 

Phrase: "Biol."
Processing 00000000.tx.311: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.312: 267, 22362-22368[Abstract/Free FullText] 8. 

Phrase: "267,"

Phrase: "22362-22368"

Phrase: "[Abstract/Free FullText"

Phrase: "] 8."
Processing 00000000.tx.313: Ma, C.-P., Vu, J. 

Phrase: "Ma,"

Phrase: "C.-P.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Vu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042321:VU [Geographic Area]

Phrase: "J."
Processing 00000000.tx.314: H., Proske, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Proske,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.315: J., Slaughter, C. 

Phrase: "J.,"

Phrase: "Slaughter,"

Phrase: "C."
Processing 00000000.tx.316: A., and DeMartino, G. 

Phrase: "A.,"

Phrase: "and"

Phrase: "DeMartino,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.317: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.318: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.319: Biol. 

Phrase: "Biol."
Processing 00000000.tx.320: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.321: 269, 3539-3547[Abstract/Free FullText] 9. 

Phrase: "269,"

Phrase: "3539-3547"

Phrase: "[Abstract/Free FullText"

Phrase: "] 9."
Processing 00000000.tx.322: Rubin, D. 

Phrase: "Rubin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0252873:rubin's [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "D."
Processing 00000000.tx.323: M., Glickman, M. 

Phrase: "M."

Phrase: ","

Phrase: "Glickman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.324: H., Larsen, C. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Larsen,"

Phrase: "C."
Processing 00000000.tx.325: N., Druvakumar, S., and Finley, D. 

Phrase: "N., Druvakumar,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Finley,"

Phrase: "D."
Processing 00000000.tx.326: (1998) EMBO J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.327: 17, 4909-4919[Abstract/Free FullText] 10. 

Phrase: "17,"

Phrase: "4909-4919"

Phrase: "[Abstract/Free FullText"

Phrase: "] 10."
Processing 00000000.tx.328: Deveraux, Q., Ustrell, V., Pickart, C., and Rechsteiner, M. 

Phrase: "Deveraux,"

Phrase: "Q.,"

Phrase: "Ustrell,"

Phrase: "V.,"

Phrase: "Pickart,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Rechsteiner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.329: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.330: Biol. 

Phrase: "Biol."
Processing 00000000.tx.331: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.332: 269, 7059-7061[Abstract/Free FullText] 11. 

Phrase: "269,"

Phrase: "7059-7061"

Phrase: "[Abstract/Free FullText"

Phrase: "] 11."
Processing 00000000.tx.333: van Nocker, S., Sadis, S., Rubin, D. 

Phrase: "van Nocker,"

Phrase: "S."

Phrase: ","

Phrase: "Sadis,"

Phrase: "S."

Phrase: ","

Phrase: "Rubin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0252873:rubin's [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "D."
Processing 00000000.tx.334: M., Glickman, M. 

Phrase: "M."

Phrase: ","

Phrase: "Glickman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.335: H., Fu, H., Coux, O., Wefes, I., Finley, D., and Vierstra, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
  1000   C1424823:FU [Gene or Genome]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Coux,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Wefes,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Finley,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Vierstra,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.336: D. 

Phrase: "D."
Processing 00000000.tx.337: (1996) Mol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.338: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.339: Biol. 

Phrase: "Biol."
Processing 00000000.tx.340: 16, 6020-6028[Abstract] 12. 

Phrase: "16,"

Phrase: "6020-6028"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 12."
Processing 00000000.tx.341: Kominami, K., Okura, N., Kawamura, M., DeMartino, G. 

Phrase: "Kominami,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Okura,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kawamura,"

Phrase: "M."

Phrase: ","

Phrase: "DeMartino,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.342: N., Slaughter, C. 

Phrase: "N., Slaughter,"

Phrase: "C."
Processing 00000000.tx.343: A., Simbara, N., Chung, C. 

Phrase: "A.,"

Phrase: "Simbara,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Chung,"

Phrase: "C."
Processing 00000000.tx.344: H., Fujimuro, M., Yokosawa, H., Shimizu, Y., Tanahashi, N., Tanaka, K., and Toh-e, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fujimuro,"

Phrase: "M."

Phrase: ","

Phrase: "Yokosawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shimizu,"

Phrase: "Y.,"

Phrase: "Tanahashi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tanaka,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Toh-e,"

Phrase: "A."
Processing 00000000.tx.345: (1997) Mol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.346: Biol. 

Phrase: "Biol."
Processing 00000000.tx.347: Cell 8, 171-187[Abstract] 13. 

Phrase: "Cell 8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "171-187"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 13."
Processing 00000000.tx.348: Adams, G. 

Phrase: "Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.349: M., Falke, S., Goldberg, A. 

Phrase: "M."

Phrase: ","

Phrase: "Falke,"

Phrase: "S."

Phrase: ","

Phrase: "Goldberg,"

Phrase: "A."
Processing 00000000.tx.350: L., Slaughter, C. 

Phrase: "L., Slaughter,"

Phrase: "C."
Processing 00000000.tx.351: A., DeMartino, G. 

Phrase: "A.,"

Phrase: "DeMartino,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.352: N., and Gogol, E. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Gogol,"

Phrase: "E."
Processing 00000000.tx.353: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.354: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.355: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.356: Biol. 

Phrase: "Biol."
Processing 00000000.tx.357: 273, 646-657[CrossRef][Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "273,"

Phrase: "646-657"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.358: Larsen, C. 

Phrase: "Larsen,"

Phrase: "C."
Processing 00000000.tx.359: N., and Finley, D. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Finley,"

Phrase: "D."
Processing 00000000.tx.360: (1997) Cell 91, 431-434[Medline] [OrderarticleviaInfotrieve] 15. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Cell 91,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "431-434"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 15."
Processing 00000000.tx.361: Wenzel, T., and Baumeister, W. 

Phrase: "Wenzel,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Baumeister,"

Phrase: "W."
Processing 00000000.tx.362: (1995) Nat. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.363: Struct. 

Phrase: "Struct."
Processing 00000000.tx.364: Biol. 

Phrase: "Biol."
Processing 00000000.tx.365: 2, 199-204[Medline] [OrderarticleviaInfotrieve] 16. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "199-204"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 16."
Processing 00000000.tx.366: DeMartino, G. 

Phrase: "DeMartino,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.367: N., Moomaw, C. 

Phrase: "N., Moomaw,"

Phrase: "C."
Processing 00000000.tx.368: R., Zagnitko, O. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Zagnitko,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.369: P., Proske, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Proske,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.370: J., Ma, C.-P., Afendis, S. 

Phrase: "J.,"

Phrase: "Ma,"

Phrase: "C.-P.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Afendis,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.371: J., Swaffield, J. 

Phrase: "J.,"

Phrase: "Swaffield,"

Phrase: "J."
Processing 00000000.tx.372: C., and Slaughter, C. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Slaughter,"

Phrase: "C."
Processing 00000000.tx.373: A. 

Phrase: "A."
Processing 00000000.tx.374: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.375: Biol. 

Phrase: "Biol."
Processing 00000000.tx.376: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.377: 269, 20878-20884[Abstract/Free FullText] 17. 

Phrase: "269,"

Phrase: "20878-20884"

Phrase: "[Abstract/Free FullText"

Phrase: "] 17."
Processing 00000000.tx.378: Wickner, S., Gottesman, S., Skowyra, D., Hoskins, J., McKenney, K., and Maurizi, M. 

Phrase: "Wickner,"

Phrase: "S."

Phrase: ","

Phrase: "Gottesman,"

Phrase: "S."

Phrase: ","

Phrase: "Skowyra,"

Phrase: "D."

Phrase: ","

Phrase: "Hoskins,"

Phrase: "J.,"

Phrase: "McKenney,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Maurizi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.379: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.380: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.381: Natl. 

Phrase: "Natl."
Processing 00000000.tx.382: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.383: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.384: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.385: 91, 12218-12222[Abstract/Free FullText] 18. 

Phrase: "91,"

Phrase: "12218-12222"

Phrase: "[Abstract/Free FullText"

Phrase: "] 18."
Processing 00000000.tx.386: Pak, M., Hoskins, J. 

Phrase: "Pak,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030211:PAK [Geographic Area]

Phrase: "M."

Phrase: ","

Phrase: "Hoskins,"

Phrase: "J."
Processing 00000000.tx.387: R., Singh, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Singh,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.388: K., Maurizi, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Maurizi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.389: R., and Wickner, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Wickner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.390: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.391: Biol. 

Phrase: "Biol."
Processing 00000000.tx.392: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.393: 274, 19316-19322[Abstract/Free FullText] 19. 

Phrase: "274,"

Phrase: "19316-19322"

Phrase: "[Abstract/Free FullText"

Phrase: "] 19."
Processing 00000000.tx.394: Weber-Ban, E., Reid, B. 

Phrase: "Weber-Ban,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683610:ban [Social Behavior]

Phrase: "E.,"

Phrase: "Reid,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.395: G., Miranker, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Miranker,"

Phrase: "A."
Processing 00000000.tx.396: D., and Horwich, A. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Horwich,"

Phrase: "A."
Processing 00000000.tx.397: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.398: (1999) Nature 401, 90-93[CrossRef][Medline] [OrderarticleviaInfotrieve] 20. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 401,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "90-93"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 20."
Processing 00000000.tx.399: Levchenko, I., Luo, L., and Baker, T. 

Phrase: "Levchenko,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.400: A. 

Phrase: "A."
Processing 00000000.tx.401: (1995) Genes Dev. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.402: 9, 2399-2408[Abstract] 21. 

Phrase: "9,"

Phrase: "2399-2408"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 21."
Processing 00000000.tx.403: DeMartino, G. 

Phrase: "DeMartino,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.404: N., Proske, R. 

Phrase: "N., Proske,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.405: J., Moomaw, C. 

Phrase: "J.,"

Phrase: "Moomaw,"

Phrase: "C."
Processing 00000000.tx.406: R., Strong, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Strong,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0442821:Strong [Qualitative Concept]
   928 E C0237897:Strength [Quantitative Concept]
   928 E C0808080:Strength [Idea or Concept]
   928 E C1705922:Strength [Qualitative Concept]

Phrase: "A."
Processing 00000000.tx.407: A., Song, X., Hisamatsu, H., Tanaka, K., and Slaughter, C. 

Phrase: "A.,"

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "X.,"

Phrase: "Hisamatsu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tanaka,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Slaughter,"

Phrase: "C."
Processing 00000000.tx.408: A. 

Phrase: "A."
Processing 00000000.tx.409: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.410: Biol. 

Phrase: "Biol."
Processing 00000000.tx.411: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.412: 272, 3112-3118[CrossRef] 22. 

Phrase: "272,"

Phrase: "3112-3118"

Phrase: "[CrossRef"

Phrase: "] 22."
Processing 00000000.tx.413: McGuire, M. 

Phrase: "McGuire,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.414: J., McCullough, M. 

Phrase: "J.,"

Phrase: "McCullough,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.415: L., Croall, D. 

Phrase: "L., Croall,"

Phrase: "D."
Processing 00000000.tx.416: E., and DeMartino, G. 

Phrase: "E.,"

Phrase: "and"

Phrase: "DeMartino,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.417: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.418: (1989) Biochim. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.419: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.420: Acta 995, 181-186[Medline] [OrderarticleviaInfotrieve] 23. 

Phrase: "Acta 995,"

Phrase: "181-186"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.421: Ma, C.-P., Slaughter, C. 

Phrase: "Ma,"

Phrase: "C.-P.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Slaughter,"

Phrase: "C."
Processing 00000000.tx.422: A., and DeMartino, G. 

Phrase: "A.,"

Phrase: "and"

Phrase: "DeMartino,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.423: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.424: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.425: Biol. 

Phrase: "Biol."
Processing 00000000.tx.426: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.427: 267, 10515-10523[Abstract/Free FullText] 24. 

Phrase: "267,"

Phrase: "10515-10523"

Phrase: "[Abstract/Free FullText"

Phrase: "] 24."
Processing 00000000.tx.428: Glickman, M. 

Phrase: "Glickman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.429: H., Rubin, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0252873:rubin's [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "D."
Processing 00000000.tx.430: M., Coux, O., Wefes, I., Preifer, G., Cjeka, Z., Baumeister, W., Fried, V. 

Phrase: "M."

Phrase: ","

Phrase: "Coux,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Wefes,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Preifer,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Cjeka,"

Phrase: "Z.,"

Phrase: "Baumeister,"

Phrase: "W.,"

Phrase: "Fried,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1825319:FRY [Gene or Genome]

Phrase: "V."
Processing 00000000.tx.431: A., and Finley, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Finley,"

Phrase: "D."
Processing 00000000.tx.432: (1998) Cell 94, 615-623[Medline] [OrderarticleviaInfotrieve] 25. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Cell 94,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "615-623"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 25."
Processing 00000000.tx.433: Qu, B.-H., and Thomas, P. 

Phrase: "Qu,"

Phrase: "B.-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Thomas,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.434: J. 

Phrase: "J."
Processing 00000000.tx.435: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.436: Biol. 

Phrase: "Biol."
Processing 00000000.tx.437: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.438: 271, 7261-7264[Abstract/Free FullText] 26. 

Phrase: "271,"

Phrase: "7261-7264"

Phrase: "[Abstract/Free FullText"

Phrase: "] 26."
Processing 00000000.tx.439: Strickland, E., Qu, B.-H., Millen, L., and Thomas, P. 

Phrase: "Strickland,"

Phrase: "E.,"

Phrase: "Qu,"

Phrase: "B.-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Millen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Thomas,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.440: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.441: Biol. 

Phrase: "Biol."
Processing 00000000.tx.442: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.443: 272, 25421-25424[Abstract/Free FullText] 27. 

Phrase: "272,"

Phrase: "25421-25424"

Phrase: "[Abstract/Free FullText"

Phrase: "] 27."
Processing 00000000.tx.444: Bardwell, J. 

Phrase: "Bardwell,"

Phrase: "J."
Processing 00000000.tx.445: C., McGovern, K., and Beckwith, J. 

Phrase: "C., McGovern,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Beckwith,"

Phrase: "J."
Processing 00000000.tx.446: (1991) Cell 67, 581-589[Medline] [OrderarticleviaInfotrieve] 28. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Cell 67,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "581-589"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 28."
Processing 00000000.tx.447: Holmgren, A. 

Phrase: "Holmgren,"

Phrase: "A."
Processing 00000000.tx.448: (1979) J. 

Phrase: "(1979"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.449: Biol. 

Phrase: "Biol."
Processing 00000000.tx.450: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.451: 254, 9627-9632[Abstract] 29. 

Phrase: "254,"

Phrase: "9627-9632"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 29."
Processing 00000000.tx.452: Buchner, J., Grallert, H., and Jakob, U. 

Phrase: "Buchner,"

Phrase: "J.,"

Phrase: "Grallert,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Jakob,"

Phrase: "U."
Processing 00000000.tx.453: (1998) Methods Enzymol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.454: 290, 323-338[CrossRef][Medline] [OrderarticleviaInfotrieve] 30. 

Phrase: "290,"

Phrase: "323-338"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 30."
Processing 00000000.tx.455: Lee, G. 

Phrase: "Lee,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.456: J. 

Phrase: "J."
Processing 00000000.tx.457: (1995) Methods Cell Biol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Methods Cell Biol."
Processing 00000000.tx.458: 50, 325-334[Medline] [OrderarticleviaInfotrieve] 31. 

Phrase: "50,"

Phrase: "325-334"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.459: Srere, P. 

Phrase: "Srere,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.460: A., and Kosicki, G. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Kosicki,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.461: W. 

Phrase: "W."
Processing 00000000.tx.462: (1961) J. 

Phrase: "(1961"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.463: Biol. 

Phrase: "Biol."
Processing 00000000.tx.464: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.465: 236, 2557-2559[Medline] [OrderarticleviaInfotrieve] 32. 

Phrase: "236,"

Phrase: "2557-2559"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 32."
Processing 00000000.tx.466: Qu, B. 

Phrase: "Qu,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.467: H., Strickland, E., and Thomas, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Strickland,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Thomas,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.468: J. 

Phrase: "J."
Processing 00000000.tx.469: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.470: Bioenerg. 

Phrase: "Bioenerg."
Processing 00000000.tx.471: Biomembr. 

Phrase: "Biomembr."
Processing 00000000.tx.472: 29, 483-490[CrossRef][Medline] [OrderarticleviaInfotrieve] 33. 

Phrase: "29,"

Phrase: "483-490"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 33."
Processing 00000000.tx.473: Cheng, S. 

Phrase: "Cheng,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.474: H., Gregory, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gregory,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.475: J., Marshall, J., Paul, S., Souza, D. 

Phrase: "J.,"

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "J.,"

Phrase: "Paul,"

Phrase: "S."

Phrase: ","

Phrase: "Souza,"

Phrase: "D."
Processing 00000000.tx.476: W., White, G. 

Phrase: "W., White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007457:White [Population Group]
   861   C0043157:White [Population Group]
   861   C0220938:White [Qualitative Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.477: A., O'Riordan, C. 

Phrase: "A.,"

Phrase: "O'Riordan,"

Phrase: "C."
Processing 00000000.tx.478: R., and Smith, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.479: E. 

Phrase: "E."
Processing 00000000.tx.480: (1990) Cell 63, 827-834[Medline] [OrderarticleviaInfotrieve] 34. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Cell 63,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "827-834"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 34."
Processing 00000000.tx.481: Thomas, P. 

Phrase: "Thomas,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.482: J., and Pedersen, P. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Pedersen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.483: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.484: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.485: Bioenerg. 

Phrase: "Bioenerg."
Processing 00000000.tx.486: Biomembr. 

Phrase: "Biomembr."
Processing 00000000.tx.487: 25, 11-19[Medline] [OrderarticleviaInfotrieve] 35. 

Phrase: "25,"

Phrase: "11-19"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 35."
Processing 00000000.tx.488: Yang, Y., Janich, S., Cohn, J. 

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "Y.,"

Phrase: "Janich,"

Phrase: "S."

Phrase: ","

Phrase: "Cohn,"

Phrase: "J."
Processing 00000000.tx.489: A., and Wilson, J. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Wilson,"

Phrase: "J."
Processing 00000000.tx.490: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.491: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.492: Natl. 

Phrase: "Natl."
Processing 00000000.tx.493: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.494: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.495: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.496: 90, 9480-9484[Abstract] 36. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "9480-9484"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 36."
Processing 00000000.tx.497: Pind, S., Riordan, J. 

Phrase: "Pind"

Phrase: ","

Phrase: "S."

Phrase: ","

Phrase: "Riordan,"

Phrase: "J."
Processing 00000000.tx.498: R., and Williams, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Williams,"

Phrase: "D."
Processing 00000000.tx.499: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.500: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.501: Biol. 

Phrase: "Biol."
Processing 00000000.tx.502: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.503: 269, 12784-12788[Abstract/Free FullText] 37. 

Phrase: "269,"

Phrase: "12784-12788"

Phrase: "[Abstract/Free FullText"

Phrase: "] 37."
Processing 00000000.tx.504: Ward, C. 

Phrase: "Ward,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1305702:Ward [Health Care Related Organization,Manufactured Object]
  1000   C1547134:Ward [Idea or Concept]
  1000   C2355574:Ward [Population Group]

Phrase: "C."
Processing 00000000.tx.505: L., Omura, S., and Kopito, R. 

Phrase: "L., Omura,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Kopito,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.506: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.507: (1995) Cell 83, 121-127[Medline] [OrderarticleviaInfotrieve] 38. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cell 83,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "121-127"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 38."
Processing 00000000.tx.508: Jensen, T. 

Phrase: "Jensen,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.509: J., Loo, M. 

Phrase: "J.,"

Phrase: "Loo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.510: A., Pind, S., Williams, D. 

Phrase: "A.,"

Phrase: "Pind"

Phrase: ","

Phrase: "S."

Phrase: ","

Phrase: "Williams,"

Phrase: "D."
Processing 00000000.tx.511: B., Goldberg, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Goldberg,"

Phrase: "A."
Processing 00000000.tx.512: L., and Riordan, J. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Riordan,"

Phrase: "J."
Processing 00000000.tx.513: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.514: (1995) Cell 83, 129-135[Medline] [OrderarticleviaInfotrieve] 39. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cell 83,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "129-135"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 39."
Processing 00000000.tx.515: Zhi, W., Landry, S. 

Phrase: "Zhi,"

Phrase: "W.,"

Phrase: "Landry,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.516: J., Gierasch, L. 

Phrase: "J.,"

Phrase: "Gierasch,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.517: M., and Srere, P. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Srere,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.518: A. 

Phrase: "A."
Processing 00000000.tx.519: (1992) Protein Sci. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Protein Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.520: 1, 522-529[Abstract/Free FullText] 40. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "522-529"

Phrase: "[Abstract/Free FullText"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.521: Palleros, D. 

Phrase: "Palleros,"

Phrase: "D."
Processing 00000000.tx.522: R., Welch, W. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Welch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043114:Welsh [Population Group]

Phrase: ","

Phrase: "W."
Processing 00000000.tx.523: J., and Fink, A. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Fink,"

Phrase: "A."
Processing 00000000.tx.524: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.525: (1991) Proc. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.526: Natl. 

Phrase: "Natl."
Processing 00000000.tx.527: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.528: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.529: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.530: 88, 5719-5723[Abstract] 41. 

Phrase: "88,"

Phrase: "5719-5723"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 41."
Processing 00000000.tx.531: Buchberger, A., Theyssen, H., Schroder, H., McCarty, J. 

Phrase: "Buchberger,"

Phrase: "A.,"

Phrase: "Theyssen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schroder,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "McCarty,"

Phrase: "J."
Processing 00000000.tx.532: S., Virgallita, G., Milkereit, P., Reinstein, J., and Bukau, B. 

Phrase: "S."

Phrase: ","

Phrase: "Virgallita,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Milkereit,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Reinstein,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Bukau,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.533: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.534: Biol. 

Phrase: "Biol."
Processing 00000000.tx.535: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.536: 270, 16903-16910[Abstract/Free FullText] 42. 

Phrase: "270,"

Phrase: "16903-16910"

Phrase: "[Abstract/Free FullText"

Phrase: "] 42."
Processing 00000000.tx.537: Palleros, D. 

Phrase: "Palleros,"

Phrase: "D."
Processing 00000000.tx.538: R., Reid, K. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Reid,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.539: L., Shi, L., Welch, W. 

Phrase: "L., Shi,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Welch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043114:Welsh [Population Group]

Phrase: ","

Phrase: "W."
Processing 00000000.tx.540: J., and Fink, A. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Fink,"

Phrase: "A."
Processing 00000000.tx.541: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.542: (1993) Nature 365, 664-666[CrossRef][Medline] [OrderarticleviaInfotrieve] 43. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Nature 365,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "664-666"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 43."
Processing 00000000.tx.543: Szabo, A., Langer, T., Schroder, H., Flanagan, J., Bukau, B., and Hartl, F. 

Phrase: "Szabo,"

Phrase: "A.,"

Phrase: "Langer,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schroder,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Flanagan,"

Phrase: "J.,"

Phrase: "Bukau,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Hartl,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.544: U. 

Phrase: "U."
Processing 00000000.tx.545: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.546: Natl. 

Phrase: "Natl."
Processing 00000000.tx.547: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.548: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.549: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.550: 91, 10345-10349[Abstract/Free FullText] 44. 

Phrase: "91,"

Phrase: "10345-10349"

Phrase: "[Abstract/Free FullText"

Phrase: "] 44."
Processing 00000000.tx.551: Liberek, K., Skowyra, D., Zylick, M., Johnson, C., and Georgopoulos, C. 

Phrase: "Liberek,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Skowyra,"

Phrase: "D."

Phrase: ","

Phrase: "Zylick,"

Phrase: "M."

Phrase: ","

Phrase: "Johnson,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Georgopoulos,"

Phrase: "C."
Processing 00000000.tx.552: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.553: Biol. 

Phrase: "Biol."
Processing 00000000.tx.554: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.555: 266, 14491-14496[Abstract/Free FullText] 45. 

Phrase: "266,"

Phrase: "14491-14496"

Phrase: "[Abstract/Free FullText"

Phrase: "] 45."
Processing 00000000.tx.556: Scheibel, T., Weikl, T., and Buchner, J. 

Phrase: "Scheibel,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Weikl,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Buchner,"

Phrase: "J."
Processing 00000000.tx.557: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.558: Natl. 

Phrase: "Natl."
Processing 00000000.tx.559: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.560: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.561: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.562: 95, 1495-1499[Abstract/Free FullText] 46. 

Phrase: "95,"

Phrase: "1495-1499"

Phrase: "[Abstract/Free FullText"

Phrase: "] 46."
Processing 00000000.tx.563: Hhfeld, J., Minami, Y., and Hartl, F. 

Phrase: "Hhfeld,"

Phrase: "J.,"

Phrase: "Minami,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Hartl,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.564: U. 

Phrase: "U."
Processing 00000000.tx.565: (1995) Cell 83, 589-598[Medline] [OrderarticleviaInfotrieve] 47. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cell 83,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "589-598"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 47."
Processing 00000000.tx.566: Hoffman, L., and Rechsteiner, M. 

Phrase: "Hoffman,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Rechsteiner,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.567: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.568: Biol. 

Phrase: "Biol."
Processing 00000000.tx.569: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.570: 271, 32538-32545[Abstract/Free FullText] 48. 

Phrase: "271,"

Phrase: "32538-32545"

Phrase: "[Abstract/Free FullText"

Phrase: "] 48."
Processing 00000000.tx.571: Glickman, M., Rubin, D. 

Phrase: "Glickman,"

Phrase: "M."

Phrase: ","

Phrase: "Rubin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0252873:rubin's [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "D."
Processing 00000000.tx.572: M., Fried, V. 

Phrase: "M."

Phrase: ","

Phrase: "Fried,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1825319:FRY [Gene or Genome]

Phrase: "V."
Processing 00000000.tx.573: A., Fischer, J. 

Phrase: "A.,"

Phrase: "Fischer,"

Phrase: "J."
Processing 00000000.tx.574: E., and Finley, D. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Finley,"

Phrase: "D."
Processing 00000000.tx.575: (1998) Mol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.576: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.577: Biol. 

Phrase: "Biol."
Processing 00000000.tx.578: 18, 3149-3162[Abstract/Free FullText] 49. 

Phrase: "18,"

Phrase: "3149-3162"

Phrase: "[Abstract/Free FullText"

Phrase: "] 49."
Processing 00000000.tx.579: Lam, Y. 

Phrase: "Lam,"

Phrase: "Y."
Processing 00000000.tx.580: A., Xu, W., DeMartino, G. 

Phrase: "A.,"

Phrase: "Xu,"

Phrase: "W.,"

Phrase: "DeMartino,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.581: N., and Cohen, R. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Cohen,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.582: E. 

Phrase: "E."
Processing 00000000.tx.583: (1997) Nature 385, 737-740[CrossRef][Medline] [OrderarticleviaInfotrieve] 50. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nature 385,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "737-740"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 50."
Processing 00000000.tx.584: Hartl, F. 

Phrase: "Hartl,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.585: U. 

Phrase: "U."
Processing 00000000.tx.586: (1996) Nature 381, 571-580[CrossRef][Medline] [OrderarticleviaInfotrieve] 51. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nature 381,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "571-580"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 51."
Processing 00000000.tx.587: Bukau, B., and Horwich, A. 

Phrase: "Bukau,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Horwich,"

Phrase: "A."
Processing 00000000.tx.588: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.589: (1998) Cell 92, 351-356[Medline] [OrderarticleviaInfotrieve] 52. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Cell 92,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "351-356"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 52."
Processing 00000000.tx.590: Fink, A. 

Phrase: "Fink,"

Phrase: "A."
Processing 00000000.tx.591: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.592: (1999) Physiol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Physiol."
Processing 00000000.tx.593: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.594: 79, 425-449[Abstract/Free FullText] 53. 

Phrase: "79,"

Phrase: "425-449"

Phrase: "[Abstract/Free FullText"

Phrase: "] 53."
Processing 00000000.tx.595: Clarke, A. 

Phrase: "Clarke,"

Phrase: "A."
Processing 00000000.tx.596: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.597: (1996) Curr. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.598: Opin. 

Phrase: "Opin."
Processing 00000000.tx.599: Struct. 

Phrase: "Struct."
Processing 00000000.tx.600: Biol. 

Phrase: "Biol."
Processing 00000000.tx.601: 6, 43-50[CrossRef][Medline] [OrderarticleviaInfotrieve] 54. 

Phrase: "6,"

Phrase: "43-50"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 54."
Processing 00000000.tx.602: Bercovich, B., Stancovski, I., Mayer, A., Blumenfeld, N., Laszlo, A., Schwartz, A., and Ciechanover, A. 

Phrase: "Bercovich,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Stancovski,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Mayer,"

Phrase: "A.,"

Phrase: "Blumenfeld,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Laszlo,"

Phrase: "A.,"

Phrase: "Schwartz,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Ciechanover,"

Phrase: "A."
Processing 00000000.tx.603: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.604: Biol. 

Phrase: "Biol."
Processing 00000000.tx.605: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.606: 272, 9002-9010[Abstract/Free FullText] 55. 

Phrase: "272,"

Phrase: "9002-9010"

Phrase: "[Abstract/Free FullText"

Phrase: "] 55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.607: Gottesman, S., Wickner, S., and Maurizi, M. 

Phrase: "Gottesman,"

Phrase: "S."

Phrase: ","

Phrase: "Wickner,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Maurizi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.608: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.609: (1997) Genes Dev. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.610: 11, 815-823[CrossRef][Medline] [OrderarticleviaInfotrieve] 56. 

Phrase: "11,"

Phrase: "815-823"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 56."
Processing 00000000.tx.611: Russell, S. 

Phrase: "Russell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979971:Russell [Laboratory Procedure]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.612: J., Reed, S. 

Phrase: "J.,"

Phrase: "Reed,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.613: H., Huang, W., Friedberg, E. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Huang,"

Phrase: "W.,"

Phrase: "Friedberg,"

Phrase: "E."
Processing 00000000.tx.614: C., and Johnston, S. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Johnston,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.615: A. 

Phrase: "A."
Processing 00000000.tx.616: (1999) Mol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.617: Cell 3, 687-695[CrossRef][Medline] [OrderarticleviaInfotrieve] 57. 

Phrase: "Cell 3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "687-695"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 57."
Processing 00000000.tx.618: Braun, B. 

Phrase: "Braun,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.619: C., Glickman, M., Kraft, R., Dahlmann, B., Kloetzel, P.-M., Finley, D., and Schmidt, M. 

Phrase: "C., Glickman,"

Phrase: "M."

Phrase: ","

Phrase: "Kraft,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dahlmann,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kloetzel,"

Phrase: "P.-M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Finley,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Schmidt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.620: (1999) Nat. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.621: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.622: 1, 221-226[CrossRef][Medline] [OrderarticleviaInfotrieve] Copyright  2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "221-226"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  2000 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

